Peripheral Vascular Devices Market Analysis, Size, Trends | Europe | 2023-2029 | MedSuite | Includes: Peripheral Vascular Stent Market, Stent Graft Market,Transcatheter Embolization Market & 15 more

  • Year: 2023
  • Scope: 2019-2029
  • Region: Europe
  • Pages: 1041
  • Published Date: 06/05/23
  • Type: MedSuite

Product Description

In 2022, the European Peripheral Vascular Devices Market was valued at around €1.5 billion, and it is projected to grow at a CAGR of 3.1% during the forecast period. As a result, it is anticipated to reach approximately €1.9 billion.

Throughout this medical device market research, we analyzed over 50 companies within the peripheral vascular device market across Europe and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and average sales prices (ASPs) to create accurate forecasts.

The full report suite on the European market for peripheral vascular (PV) devices includes comprehensive analysis on peripheral vascular stents, percutaneous transluminal angioplasty (PTA) balloon catheters, drug coated balloons (DCBs), atherectomy devices, intravascular lithotripsy (IVL) system, chronic total occlusion (CTO) devices, surgical grafts, stent grafts, embolic protection devices (EPDs), arteriovenous (AV) access thrombectomy devices, inferior vena cava filters, carotid shunts, diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths, vascular closure devices (VCDs), transcatheter embolization devices and peripheral intravascular ultrasound (IVUS) catheters .

Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2029, and Historical Data to 2019
  • Market Drivers & Limiters for Each Peripheral Vascular Device market
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

European Peripheral Vascular Devices Market Insights

The COVID-19 pandemic had a notable impact on the PV market in Europe in 2020. Government-imposed restrictions and lockdown measures resulted in procedure delays and cancellations, leading to reduced demand and lower sales for PV device companies. However, as lockdown measures eased and procedures resumed, companies in the PV market regained their market position. In 2021 and 2022, as postponed procedures were addressed, there was an increase in the demand for PV devices.

EU Peripheral Vascular Market Size by Segment, 2019 - 2029The IVL (Intravascular Lithotripsy) market in Europe in particular has experienced substantial growth in recent years. This innovative non-invasive technology utilizes sound waves to break down calcium buildup in arteries, providing a more efficient and less invasive alternative to traditional treatments for peripheral arterial disease. The increasing prevalence of peripheral artery disease and the growing demand for minimally invasive treatment options have contributed to the rising popularity of the IVL market in Europe.

European Peripheral Vascular Devices Market Share Insights

EU Peripheral Vascular Devices Market Share Leaders

Medtronic emerged as the market leader in Europe in 2022, driven by its strong presence in the stent graft market and extensive product portfolio. The company’s ability to capture large shares of high-value markets has allowed it to bundle lower-priced products, enhancing its overall market presence. Medtronic’s key offerings in this market include the Admiral IN.PACT™ drug-coated balloons, Endurant™ and Valiant™ stent grafts, and a range of stents and PTA balloons that generate significant revenue. Additionally, Medtronic has dominated the atherectomy device market, despite it being a smaller market in Europe.

Cook Medical achieved the second-leading position in the PV market, primarily driven by its strong presence in the stent graft market. The company also led the inferior vena cava filter (IVCF) market, although it does not contribute significantly to its revenue due to its small market size. Cook Medical’s Zenith® family of stent grafts stands out as the company’s leading product in the overall market.

After the merger with BTG in 2019, Boston Scientific emerged as the second-leading competitor in the European market. However, it later slipped to the third position in 2022 due to market share loss to Cook Medical. Despite this, Boston Scientific has made notable advancements in its venous treatment and transcatheter embolization portfolios following the acquisition, establishing a leading position in both markets. As one of the few companies with a comprehensive portfolio for treating venous diseases, Boston Scientific is anticipated to gradually gain market share in the overall PV market over time.

Research Regional Coverage

Throughout this research series, iData Research has covered several countries in great detail including:

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Benelux (Belgium, Netherlands, and Luxembourg)
  • Switzerland
  • Austria
  • Portugal
  • Scandinavia (Denmark, Finland, Norway and Sweden)

Segments Covered

  • Peripheral Vascular Stent Market
  • PTA Balloon Catheter Market
  • Drug-Coated Balloon Market
  • Atherectomy Device Market
  • Intravascular Lithotripsy Market
  • CTO Device Market
  • Surgical Graft Market
  • Stent Graft Market
  • Embolic Protection Device Market
  • Peripheral Thrombus Management Market
  • Inferior Vena Cava Filter Market
  • Carotid Shunt Market
  • Diagnostic and Interventional Catheter Market
  • Diagnostic and Interventional Guidewire Market
  • Introducer Sheath Market
  • Vascular Closure Device Market
  • Transcatheter Embolization Market
  • Peripheral IVUS Market

RESEARCH SCOPE SUMMARY

Report AttributeDetails
RegionsWestern Europe

Central & Eastern Europe

Base Year2022
Forecast2023-2029
Historical Data2019-2022
Quantitative CoverageMarket Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative CoverageCOVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data SourcesPrimary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

WHY CHOOSE IDATA?

  • Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
  • Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
  • Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
  • Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.

DON’T SEE THE SEGMENT OR DATA YOU NEED?

Feel free to contact us or send a request by pressing one of the buttons below.

FREE Sample Report

TABLE of CONTENTS
TABLE of CONTENTSi
List of Figuresxvii
List of Chartsliii
executive summary1
European Peripheral Vascular Device Market Overview1
Competitive Analysis4
Market Trends8
Market Developments12
Procedure Numbers13
Markets Included16
Key Report Updates19
Version History20
research methodology21
Step 1: Project Initiation & Team Selection21
Step 2: Prepare Data Systems and Perform Secondary Research24
Step 3: Preparation for Interviews & Questionnaire Design26
Step 4: Performing Primary Research27
Step 5: Research Analysis: Establishing Baseline Estimates29
Step 6: Market Forecast and Analysis30
Step 7: Identify Strategic Opportunities32
Step 8: Final Review and Market Release33
Step 9: Customer Feedback and Market Monitoring34
impact of covid-19 on THE European peripheral vascular device Market35
2.1 Introduction35
2.2 Country Profile37
2.3 Analysis By Market Segment38
2.3.1 Worst Case Scenario38
2.3.2 Base Case Scenario40
2.3.3 Best Case Scenario42
Disease Overview45
3.1 Basic Anatomy45
3.2 Disease Treatments & Diagnostics46
3.2.1 Aortic Aneurysms46
3.2.2 Atherosclerosis47
3.2.3 Peripheral Arterial Disease (PAD)48
3.2.4 Deep Vein Thrombosis49
3.2.5 Pulmonary Embolism50
3.3 Patient Demographics52
3.3.1 Aortic Aneurysms52
3.3.2 Atherosclerosis52
3.3.3 Peripheral Arterial Disease (PAD)53
3.3.4 Deep Vein Thrombosis53
3.3.5 Pulmonary Embolism54
Product Assessment56
4.1 Introduction56
4.2 Product Portfolios57
4.2.1 Peripheral Vascular Stent57
4.2.2 PTA Balloon Catheter60
4.2.3 Drug-Coated Balloon63
4.2.4 Atherectomy Device65
4.2.5 Intravascular Lithotripsy Market67
4.2.6 Chronic Total Occlusion68
4.2.7 Surgical Graft70
4.2.8 Stent Graft72
4.2.9 Embolic Protection73
4.2.10 Peripheral Thrombus Management74
4.2.11 Inferior Vena Cava Filter and Retrieval77
4.2.12 Carotid Shunt79
4.2.13 Diagnostic and Interventional Catheter80
4.2.14 Diagnostic and Interventional Guidewire83
4.2.15 Introducer Sheath86
4.2.16 Vascular Closure Device89
4.2.17 Transcatheter Embolization Device91
4.2.18 Peripheral IVUS Catheter94
4.3 Regulatory Issues and Recalls95
4.3.1 Peripheral Vascular Stent95
4.3.2 PTA Balloon Catheter100
4.3.3 Atherectomy Device103
4.3.4 Intravascular Lithotripsy Market105
4.3.5 Chronic Total Occlusion106
4.3.6 Surgical Graft107
4.3.7 Stent Graft110
4.3.8 Peripheral Thrombus Management114
4.3.9 Peripheral Thrombus Management Devices116
4.3.10 Inferior Vena Cava Filter and Retrieval117
4.3.11 Diagnostic and Interventional Catheter118
4.3.12 Diagnostic and Interventional Guidewire120
4.3.13 Introducer Sheath124
4.3.14 Transcatheter Embolization Device127
4.3.15 Peripheral IVUS Catheter129
4.4 Clinical Trials130
4.4.1 Peripheral Vascular Stent131
4.4.2 PTA Balloon Catheter138
4.4.3 Drug-Coated Balloon141
4.4.4 Atherectomy Device146
4.4.5 Intravascular Lithotripsy151
4.4.6 Surgical Graft153
4.4.7 Stent Graft154
4.4.8 Embolic Protection157
4.4.9 Peripheral Thrombus Management158
4.4.10 Inferior Vena Cava Filter & Retrieval161
4.4.11 Vascular Closure Device164
4.4.12 Transcatheter Embolization Device167
European Peripheral vascular device Market Overview170
5.1 Introduction170
5.1.1 Atherosclerosis170
5.1.2 Peripheral Arterial Disease171
5.2 Currency Exchange Rate172
5.3 Market Overview & Trend Analysis173
5.4 Drivers and Limiters182
5.4.1 Market Drivers182
5.4.2 Market Limiters183
5.5 Competitive Market Share Analysis185
5.6 Mergers and Acquisitions196
5.7 Company Profiles199
5.7.1 Abbott199
5.7.2 Becton Dickinson200
5.7.3 Boston Scientific202
5.7.4 Cardinal Health203
5.7.5 Cardiovascular Systems, Inc.204
5.7.6 Cook Medical205
5.7.7 Medtronic206
5.7.8 Penumbra207
5.7.9 Philips208
5.7.10 Shockwave Medical209
5.7.11 Silk Road Medical210
5.7.12 Terumo211
5.7.13 W.L. Gore212
5.8 SWOT Analysis213
5.8.1 Abbott213
5.8.2 Becton Dickinson215
5.8.3 Boston Scientific217
5.8.4 Cardinal Health218
5.8.5 Cardiovascular Systems, Inc.219
5.8.6 Cook Medical220
5.8.7 Medtronic221
5.8.8 Penumbra222
5.8.9 Philips223
5.8.10 Shockwave Medical224
5.8.11 Silk Road Medical225
5.8.12 Terumo226
5.8.13 W.L. Gore228
Country Profiles229
6.1 Introduction229
6.1.1 Population229
6.1.2 GDP Per Capita229
6.1.3 Price Index229
6.2 Germany230
6.3 France232
6.4 United Kingdom233
6.5 Italy234
6.6 Spain235
6.7 Benelux236
6.8 Scandinavia237
6.9 Austria238
6.10 Switzerland239
6.11 Portugal240
Procedure Numbers241
7.1 Procedures241
7.1.1 Peripheral Vascular Stent Procedures246
7.1.1.1 Arterial Stent Procedures248
7.1.1.1.1 Bare-Metal Stent Procedures250
7.1.1.1.2 Covered Stent Procedures257
7.1.1.1.3 Drug-Eluting Stent Procedures262
7.1.1.2 Venous Stent Procedures266
7.1.2 PTA Balloon Catheter Procedures268
7.1.3 Drug-Coated Balloon Procedures270
7.1.4 Atherectomy Device Procedures272
7.1.4.1 Laser Atherectomy Device Procedures274
7.1.4.2 Mechanical Atherectomy Device Procedures275
7.1.5 Intravascular Lithotripsy Procedures276
7.1.5.1 SFA and Iliac Lithotripsy Procedures279
7.1.5.2 BTK Lithotripsy Procedures280
7.1.6 CTO Device Procedures281
7.1.6.1 Re-Entry CTO Procedures283
7.1.6.2 Recanalization CTO Procedures284
7.1.7 Surgical Graft Procedures285
7.1.7.1 Total Surgical Graft Procedures by Material286
7.1.7.1.1 Polyester Surgical Graft Procedures288
7.1.7.1.2 ePTFE Surgical Graft Procedures289
7.1.7.2 Total Surgical Graft Procedures by Indication290
7.1.7.2.1 Lower-Limb Surgical Graft Procedures291
7.1.7.2.2 AV Access Surgical Graft Procedures294
7.1.7.2.3 Aorta Repair Surgical Graft Procedures295
7.1.7.2.4 Extra-Anatomical Bypass Surgical Graft Procedures298
7.1.8 Stent Graft Procedures299
7.1.8.1 AAA Stent Graft Procedures301
7.1.8.2 Fenestrated Stent Graft Procedures302
7.1.8.3 TAA Stent Graft Procedures303
7.1.9 Embolic Protection Device Procedures304
7.1.9.1 Carotid EPD Procedures306
7.1.9.2 Renal EPD Procedures307
7.1.9.3 Lower-Limb EPD Procedures308
7.1.10 Peripheral Thrombus Management Procedures309
7.1.10.1 Traditional Thrombectomy Device Procedures311
7.1.10.2 Pharmacomechanical Thrombectomy Device Procedures312
7.1.11 IVCF Placement Procedures313
7.1.11.1 Retrievable IVCF Procedures316
7.1.11.2 Permanent IVCF Procedures317
7.1.12 Carotid Shunt Procedures318
7.1.13 Vascular Closure Device Procedures320
7.1.13.1 Total Vascular Closure Device Procedures by Device Type321
7.1.13.1.1 Small-Bore Invasive VCD Procedures323
7.1.13.1.2 Large-Bore Invasive VCD Procedures324
7.1.13.1.3 Non-Invasive VCD Procedures325
7.1.13.2 Total Vascular Closure Device Procedures by Approach326
7.1.13.2.1 Radial VCD Procedures327
7.1.13.2.2 Femoral VCD Procedures328
7.1.14 Transcatheter Embolization Procedures329
7.1.14.1 Particle Embolization Procedures332
7.1.14.1.1 PVA Particle Procedures334
7.1.14.1.2 Microsphere Procedures335
7.1.14.1.3 Drug-Eluting Particle Procedures336
7.1.14.1.4 Radioactive Particle Procedures337
7.1.14.2 Coil Embolization Procedures338
7.1.14.2.1 Pushable Coil Procedures340
7.1.14.2.2 Detachable Coil Procedures341
7.1.14.3 Liquid Embolics Procedures342
7.1.14.4 Plug Embolization Procedures343
7.1.15 Peripheral IVUS Procedures344
Peripheral Vascular Stent Market346
8.1 Introduction346
8.1.1 Peripheral Arterial Stents347
8.1.1.1 Off-Label Use347
8.1.1.2 Covered Stents347
8.1.1.3 Drug-Eluting Stents348
8.1.1.4 Stent Length349
8.1.2.Venous Stents
8.2 Market Overview351
8.3 Market Analysis and Forecast355
8.3.1 Arterial Stent Market355
8.3.1.1 Total Bare-Metal Stent Market363
8.3.1.1.1 Bare-Metal Carotid Stent Market371
8.3.1.1.2 Bare-Metal Iliac Stent Market377
8.3.1.1.3 Bare-Metal Renal Stent Market383
8.3.1.1.4 Bare-Metal Fem-Pop Stent Market389
8.3.1.1.5 Bare-Metal Infra-Pop Stent Market395
8.3.1.2 Covered Stent Market401
8.3.1.3 Drug-Eluting Stent Market407
8.3.2 Venous Stent Market414
8.4 Unit Analysis421
8.4.1 Bare-Metal Stent Units Sold by Delivery Platform421
8.4.1.1 Self-Expanding Bare-Metal Stent Units422
8.4.1.2 Balloon-Expanding Bare-Metal Stent Units423
8.4.2 Bare-Metal Stent Units Sold by Stent Length424
8.4.2.1 Bare-Metal Carotid Stent Units426
8.4.2.2 Bare-Metal Iliac Stent Units427
8.4.2.3 Bare-Metal Renal Stent Units428
8.4.2.4 Bare-Metal Fem-Popliteal Stent Units429
8.4.3 Covered Stent Units Sold by Delivery Platform430
8.4.3.1 Iliac Covered Stent Units431
8.4.3.2 Fem-Pop Covered Stent Units432
8.4.3.3 AV Access Covered Stent Units433
8.4.4 Drug-Eluting Stent Units Sold by Delivery Platform434
8.4.4.1 SFA Drug-Eluting Stent Units435
8.4.4.2 Infra-Pop Drug-Eluting Stent Units436
8.5 Drivers and Limiters437
8.5.1 Market Drivers437
8.5.2 Market Limiters439
8.6 Competitive Market Share Analysis441
PTA Balloon Catheter Market447
9.1 Introduction447
9.1.1 Types of PTA Balloon Catheters447
9.2 Market Overview449
9.3 Market Analysis and Forecast453
9.3.1 Total PTA Balloon Catheter Market453
9.3.2 Standard PTA Balloon Catheter Market459
9.3.3 High-Pressure PTA Balloon Catheter Market465
9.3.4 Large PTA Balloon Catheter Market471
9.3.5 Small PTA Balloon Catheter Market477
9.3.6 Specialty PTA Balloon Catheter Market483
9.4 Drivers and Limiters489
9.4.1 Market Drivers489
9.4.2 Market Limiters490
9.5 Competitive Market Share Analysis491
Drug-Coated Balloon Market496
10.1 Introduction496
10.2 Market Analysis and Forecast497
10.3 Drivers and Limiters506
10.3.1 Market Drivers506
10.3.2 Market Limiters506
10.4 Competitive Market Share Analysis507
Atherectomy Device Market512
11.1 Introduction512
11.2 Market Overview514
11.3 Market Analysis and Forecast517
11.3.1 Total Atherectomy Device Market517
11.3.2 Laser Atherectomy Device Market524
11.3.3 Mechanical Atherectomy Device Market530
11.4 Drivers and Limiters536
11.4.1 Market Drivers536
11.4.2 Market Limiters537
11.5 Competitive Market Share Analysis538
Intravascular lithotripsy Market543
12.1 Introduction543
12.2 Market Analysis and Forecast545
12.3 Drivers and Limiters552
12.3.1 Market Drivers552
12.3.2 Market Limiters552
12.4 Competitive Market Share Analysis554
Chronic total occlusion device Market555
13.1 Introduction555
13.2 Market Overview556
13.3 Market Analysis and Forecast559
13.3.1 Total CTO Device Market559
13.3.2 Re-Entry Device Market565
13.3.3 Recanalization Device Market571
13.4 Drivers and Limiters577
13.4.1 Market Drivers577
13.4.2 Market Limiters578
13.5 Competitive Market Share Analysis579
Surgical Graft Market582
14.1 Introduction582
14.2 Market Overview583
14.3 Market Analysis and Forecast586
14.3.1 Total Lower-Limb Surgical Graft Market587
14.3.1.1 Above-the-Knee Surgical Graft Market594
14.3.1.2 Below-the-Knee Surgical Graft Market600
14.3.2 AV Access Surgical Graft Market606
14.3.3 Total Aorta Repair Surgical Graft Market612
14.3.3.1 Abdominal Aortic Aneurysm Surgical Graft Market620
14.3.3.2 Thoracic Aortic Aneurysm Surgical Graft Market626
14.3.4 Extra-Anatomical Bypass Surgical Graft Market632
14.4 Unit Analysis638
14.4.1 Surgical Graft Units Sold by Material638
14.4.1.1 Polyester Surgical Graft Units639
14.4.1.2 ePTFE Surgical Graft Units640
14.5 Drivers and Limiters641
14.5.1 Market Drivers641
14.5.2 Market Limiters642
14.6 Competitive Market Share Analysis643
stent graft Market647
15.1 Introduction647
15.2 Market Overview648
15.3 Market Analysis and Forecast651
15.3.1 Total Stent Graft Market651
15.3.2 AAA Stent Graft Market658
15.3.3 TAA Stent Graft Market664
15.3.4 Fenestrated Stent Graft Market670
15.4 Drivers and Limiters677
15.4.1 Market Drivers677
15.4.2 Market Limiters678
15.5 Competitive Market Share Analysis679
Embolic Protection Device Market684
16.1 Introduction684
16.1.1 Protection Mechanism684
16.1.1.1 Filter Basket684
16.1.1.2 Distal Balloon Occlusion685
16.1.1.3 Flow Redirection685
16.2 Market Overview686
16.3 Market Analysis and Forecast689
16.3.1 Total Embolic Protection Device Market689
16.3.2 Carotid Embolic Protection Device Market695
16.3.3 Renal Embolic Protection Device Market701
16.3.4 Lower-Limb Embolic Protection Device Market707
16.4 Drivers and Limiters713
16.4.1 Market Drivers713
16.4.2 Market Limiters713
16.5 Competitive Market Share Analysis715
Peripheral Thrombus Management Market718
17.1 Introduction718
17.1.1 AV Access Thrombectomy Devices718
17.1.2 Other Peripheral Applications of Thrombectomy Devices719
17.2 Market Overview720
17.3 Market Analysis and Forecast723
17.3.1 Total Peripheral Thrombus Management Market723
17.3.2 Traditional Thrombectomy Device Market729
17.3.3 Pharmacomechanical Thrombectomy Device Market735
17.4 Drivers and Limiters742
17.4.1 Market Drivers742
17.4.2 Market Limiters742
17.5 Competitive Market Share Analysis744
inferior vena cava filter Market747
18.1 Introduction747
18.2 Market Overview749
18.3 Market Analysis and Forecast752
18.3.1 Total Inferior Vena Cava Filter Market753
18.3.2 Retrievable IVCF Market759
18.3.3 Permanent IVCF Market765
18.4 Drivers and Limiters771
18.4.1 Market Drivers771
18.4.2 Market Limiters771
18.5 Competitive Market Share Analysis773
carotid shunt Market777
19.1 Introduction777
19.2 Market Analysis and Forecast778
19.3 Drivers and Limiters785
19.3.1 Market Drivers785
19.3.2 Market Limiters785
19.4 Competitive Market Share Analysis786
Diagnostic and Interventional Catheter Market789
20.1 Introduction789
20.2 Market Overview790
20.3 Market Analysis and Forecast793
20.3.1 Total Diagnostic and Interventional Catheter Market793
20.3.2 Total Diagnostic Catheter Market799
20.3.2.1 Standard Diagnostic Catheter Market806
20.3.2.2 Hydrophilic Diagnostic Catheter Market812
20.3.3 Support Catheter Market818
20.4 Drivers and Limiters824
20.4.1 Market Drivers824
20.4.2 Market Limiters825
20.5 Competitive Market Share Analysis826
Diagnostic and interventional guidewire Market830
21.1 Introduction830
21.2 Market Overview831
21.3 Market Analysis and Forecast834
21.3.1 Total Diagnostic and Interventional Guidewire Market834
21.3.2 Standard Guidewire Market840
21.3.3 Hydrophilic Guidewire Market846
21.4 Drivers and Limiters852
21.4.1 Market Drivers852
21.4.2 Market Limiters852
21.5 Competitive Market Share Analysis854
Introducer sheath Market858
22.1 Introduction858
22.2 Market Overview859
22.3 Market Analysis and Forecast862
22.3.1 Total Introducer Sheath Market862
22.3.2 Standard Introducer Sheath Market868
22.3.3 Guiding Introducer Sheath Market874
22.4 Drivers and Limiters880
22.4.1 Market Drivers880
22.4.2 Market Limiters880
22.5 Competitive Market Share Analysis882
Vascular Closure Device Market885
23.1 Introduction885
23.2 Market Overview887
23.2.1 Vascular Closure Device Market Overview by Device Type887
23.2.2 Vascular Closure Device Market Overview by Approach889
23.3 Market Analysis and Forecast892
23.3.1 Total Vascular Closure Device Market by Device Type892
23.3.1.1 Total Invasive Vascular Closure Device Market898
23.3.1.1.1 Small-Bore Vascular Closure Device Market905
23.3.1.1.2 Large-Bore Vascular Closure Device Market911
23.3.1.2 Non-Invasive Vascular Closure Device Market918
23.3.2 Total Vascular Closure Device Market by Approach924
23.3.2.1 Radial Vascular Closure Device Market924
23.3.2.2 Femoral Vascular Closure Device Market930
23.4 Drivers and Limiters936
23.4.1 Market Drivers936
23.4.2 Market Limiters937
23.5 Competitive Market Share Analysis938
Transcatheter Embolization Market943
24.1 Introduction943
24.1.1 Particle Embolic Devices943
24.1.2 Coil Embolic Devices944
24.1.3 Liquid Embolic Devices944
24.1.4 Vascular Plugs945
24.2 Market Overview946
24.3 Market Analysis and Forecast949
24.3.1 Particle Embolization Market949
24.3.1.1 PVA Particle Market958
24.3.1.2 Microsphere Market964
24.3.1.3 Drug-Eluting Particle Market970
24.3.1.4 Radioactive Particle Market976
24.3.2 Coil Embolization Market982
24.3.2.1 Pushable Coil Market990
24.3.2.2 Detachable Coil Market996
24.3.3 Liquid Embolization Market1002
24.3.4 Plug Embolization Market1008
24.4 Drivers and Limiters1015
24.4.1 Market Drivers1015
24.4.2 Market Limiters1015
24.5 Competitive Market Share Analysis1018
peripheral ivus Market1023
25.1 Introduction1023
25.2 Market Analysis and Forecast1024
25.3 Drivers and Limiters1033
25.3.1 Market Drivers1033
25.3.2 Market Limiters1034
25.4 Competitive Market Share Analysis1035
Abbreviations1038
The Peripheral Vascular Devices Market Report Suite | Europe | 2023-2029 | MedSuite includes analysis on the following companies currently active in this market:
Aachen Resonance GmbHLeMaitre Vascular
Abbott VascularMaquet
Acandis GmbHMedtronic
ACIST MedicalMerit Medical Systems
AcrostakMiCroPort
Affluent MedicalNatec Medical Ltd.
AngioDynamicsNordion
Argon MedicalOptimed GmbH
Asahi InteccOscor Inc.
AvimedicaPenumbra
AvingerPhilips
B. Braunplus Medica
Becton DickinsonRa Medical
Biosensors InternationalRafael Medical Technologies
BiotronikReva Medical
BiovicRex Medical
Blockade MedicalScitech Medical
Boston ScientificShockwave Medical
Cardinal HealthSirtex Medical
Cardionovum GmbHSoundBite Medical Solutions
Cardiovascular Systems, Inc.Straub Medical
CardivaTeleflex
Celenova Biosciences IncTerumo
Concept MedicalTheragenics
Contego MedicalVascular Solutions
Control Medical TechnologyVascular Flow Technologies
Cook MedicalVasorum
EndospanVarian Medical Systems
EurocorVivasure Medical
Infraredx Inc.W.L. Gore
InSeal MedicalWalk Vascular
Jotec
List of Charts
Chart 1‑1: Peripheral Vascular Device Market by Segment, Europe, 2022 – 20293
Chart 1‑2: Peripheral Vascular Device Market Overview, Europe, 2022 & 20293
Chart 2‑1: Multi-Scenario Peripheral Vascular Device Market Forecast, Europe, 2019 – 2029 (€M)44
Chart 5‑1: Peripheral Vascular Device Market by Segment, Europe, 2019 – 2029181
Chart 5‑2: Leading Competitors, Peripheral Vascular Device Market, Europe, 2022195
Chart 6‑1: Country Profile, Germany, 2022231
Chart 6‑2: Country Profile, France, 2022232
Chart 6‑3: Country Profile, United Kingdom, 2022233
Chart 6‑4: Country Profile, Italy, 2022234
Chart 6‑5: Country Profile, Spain, 2022235
Chart 6‑6: Country Profile, Benelux, 2022236
Chart 6‑7: Country Profile, Scandinavia, 2022237
Chart 6‑8: Country Profile, Austria, 2022238
Chart 6‑9: Country Profile, Switzerland, 2022239
Chart 6‑10: Country Profile, Portugal, 2022240
Chart 7‑1: Peripheral Vascular Device Procedures by Segment, Europe, 2019 – 2029245
Chart 8‑1: Peripheral Vascular Stent Market by Segment, Europe, 2019 – 2029354
Chart 8‑2: Leading Competitors, Peripheral Vascular Stent Market, Europe, 2022446
Chart 9‑1: PTA Balloon Catheter Market by Segment, Europe, 2019 – 2029452
Chart 9‑2: Leading Competitors, PTA Balloon Catheter Market, Europe, 2022495
Chart 10‑1: Drug-Coated Balloon Market, Europe, 2019 – 2029500
Chart 10‑2: Leading Competitors, Drug-Coated Balloon Market, Europe, 2022511
Chart 11‑1: Atherectomy Device Market by Segment, Europe, 2019 – 2029516
Chart 11‑2: Leading Competitors, Atherectomy Device Market, Europe, 2022542
Chart 12‑1: Intravascular Lithotripsy Market by Segment, Europe, 2019 – 2029546
Chart 13‑1: CTO Device Market by Segment, Europe, 2019 – 2029558
Chart 13‑2: Leading Competitors, CTO Device Market, Europe, 2022581
Chart 14‑1: Surgical Graft Market by Segment, Europe, 2019 – 2029585
Chart 14‑2: Leading Competitors, Surgical Graft Market, Europe, 2022646
Chart 15‑1: Stent Graft Market by Segment, Europe, 2019 – 2029650
Chart 15‑2: Leading Competitors, Stent Graft Market, Europe, 2022683
Chart 16‑1: Embolic Protection Device Market by Segment, Europe, 2019 – 2029688
Chart 16‑2: Leading Competitors, Embolic Protection Device Market, Europe, 2022717
Chart 17‑1: Peripheral Thrombus Management Market by Segment, Europe, 2019 – 2029722
Chart 17‑2: Leading Competitors, Peripheral Thrombus Management Market, Europe, 2022746
Chart 18‑1: Inferior Vena Cava Filter Market by Segment, Europe, 2019 – 2029751
Chart 18‑2: Leading Competitors, Inferior Vena Cava Filter Market, Europe, 2022776
Chart 19‑1: Carotid Shunt Market, Europe, 2019 – 2029779
Chart 19‑2: Leading Competitors, Carotid Shunt Market, Europe, 2022788
Chart 20‑1: Diagnostic and Interventional Catheter Market by Segment, Europe, 2019 – 2029792
Chart 20‑2: Leading Competitors, Diagnostic and Interventional Catheter Market, Europe, 2022829
Chart 21‑1: Diagnostic and Interventional Guidewire Market by Segment, Europe, 2019 – 2029833
Chart 21‑2: Leading Competitors, Diagnostic and Interventional Guidewire Market, Europe, 2022857
Chart 22‑1: Introducer Sheath Market by Segment, Europe, 2019 – 2029861
Chart 22‑2: Leading Competitors, Introducer Sheath Market, Europe, 2022884
Chart 23‑1: Vascular Closure Device Market by Segment, Europe, 2019 – 2029891
Chart 23‑2: Leading Competitors, Vascular Closure Device Market, Europe, 2022942
Chart 24‑1: Transcatheter Embolization Market by Segment, Europe, 2019 – 2029948
Chart 24‑2: Leading Competitors, Transcatheter Embolization Market, Europe, 20221022
Chart 25‑1: Peripheral IVUS Market, Europe, 2019 – 20291027
Chart 25‑2: Leading Competitors, Peripheral IVUS Market, Europe, 20221037
List of Figures
Figure 1‑1: Peripheral Vascular Device Market Share Ranking by Segment, Europe, 2022 (1 of 4)5
Figure 1‑2: Peripheral Vascular Device Market Share Ranking by Segment, Europe, 2022 (2 of 4)5
Figure 1‑3: Peripheral Vascular Device Market Share Ranking by Segment, Europe, 2022 (3 of 4)5
Figure 1‑4: Peripheral Vascular Device Market Share Ranking by Segment, Europe, 2022 (4 of 4)6
Figure 1‑5: Companies Researched in This Report7
Figure 1‑6: Factors Impacting the Peripheral Market by Segment, Europe (1 of 4)8
Figure 1‑7: Factors Impacting the peripheral Market by Segment, Europe (2 of 4)9
Figure 1‑8: Factors Impacting the peripheral Market by Segment, Europe (3 of 4)10
Figure 1‑9: Factors Impacting the peripheral Market by Segment, Europe (4 of 4)11
Figure 1‑10: Recent Events in the Peripheral Vascular Device Market, Europe, 2019 – 202312
Figure 1‑11: Peripheral Vascular Device Procedures Covered, Europe (1 of 3)13
Figure 1‑12: Peripheral Vascular Device Procedures Covered, Europe (2 of 3)14
Figure 1‑13: Peripheral Vascular Device Procedures Covered, Europe (3 of 3)15
Figure 1‑14: Peripheral Vascular Device Markets Covered, Europe (1 of 3)16
Figure 1‑15: Peripheral Vascular Device Markets Covered, Europe (2 of 3)17
Figure 1‑16: Peripheral Vascular Device Markets Covered, Europe (3 of 3)18
Figure 1‑17: Key Report Updates19
Figure 1‑18: Version History20
Figure 2‑1: Peripheral Vascular Device Market by Segment, Worst Case Scenario, Europe, 2019 – 2029 (€M) (1 of 2)38
Figure 2‑2: Peripheral Vascular Device Market by Segment, Worst Case Scenario, Europe, 2019 – 2029 (€M) (2 of 2)39
Figure 2‑3: Peripheral Vascular Device Market by Segment, Base Case Scenario, Europe, 2019 – 2029 (€M) (1 of 2)40
Figure 2‑4: Peripheral Vascular Device Market by Segment, Base Case Scenario, Europe, 2019 – 2029 (€M) (2 of 2)41
Figure 2‑5: Peripheral Vascular Device Market by Segment, Best Case Scenario, Europe, 2019 – 2029 (€M) (1 of 2)42
Figure 2‑6: Peripheral Vascular Device Market by Segment, Best Case Scenario, Europe, 2019 – 2029 (€M) (2 of 2)43
Figure 4‑1: Peripheral Vascular Stent by Company (1 of 2)58
Figure 4‑2: Peripheral Vascular Stent by Company (2 of 2)59
Figure 4‑3: PTA Balloon Catheter by Company (1 of 3)60
Figure 4‑4: PTA Balloon Catheter by Company (2 of 3)61
Figure 4‑5: PTA Balloon Catheter by Company (3 of 3)62
Figure 4‑6: Drug-Coated Balloon by Company64
Figure 4‑7: Atherectomy Device by Company (1 of 2)65
Figure 4‑8: Atherectomy Device by Company (2 of 2)66
Figure 4‑9: Lithotripsy Device by Company67
Figure 4‑10: Chronic Total Occlusion Device by Company69
Figure 4‑11: Surgical Graft by Company (1 of 2)70
Figure 4‑12: Surgical Graft by Company (2 of 2)71
Figure 4‑13: Stent Graft by Company72
Figure 4‑14: Embolic Protection Device by Company73
Figure 4‑15: Peripheral Thrombus Management by Company76
Figure 4‑16: Inferior Vena Cava Filter & Retrieval Device by Company (1 of 2)77
Figure 4‑17: Inferior Vena Cava Filter & Retrieval Device by Company (2 of 2)78
Figure 4‑18: Carotid Shunt by Company79
Figure 4‑19: Diagnostic and Interventional Catheters by Company (1 of 2)81
Figure 4‑20: Diagnostic and Interventional Catheters by Company (2 of 2)82
Figure 4‑21: Diagnostic and Interventional Guidewire by Company (1 of 3)83
Figure 4‑22: Diagnostic and Interventional Guidewire by Company (2 of 3)84
Figure 4‑23: Diagnostic and Interventional Guidewire by Company (3 of 3)85
Figure 4‑24: Introducer Sheath by Company (1 of 2)87
Figure 4‑25: Introducer Sheath by Company (2 of 2)88
Figure 4‑26: Vascular Closure Device by Company90
Figure 4‑27: Transcatheter Embolization Devices by Company (1 of 2)92
Figure 4‑28: Transcatheter Embolization Devices by Company (2 of 2)93
Figure 4‑29: Peripheral IVUS Catheter by Company94
Figure 4‑30: Class 2 Device Recall VENOVO Venous Stent System95
Figure 4‑31: Class 1 Device Recall VICI VENOUS STENT System95
Figure 4‑32: Class 2 Device Recall ELUVIA95
Figure 4‑33: Class 2 Device Recall PALMAZ GENESIS96
Figure 4‑34: Class 2 Device Recall S.M.A.R.T. Flex96
Figure 4‑35: Class 1 Device Recall PRECISE PRO RX CAROTID STENT Implant System96
Figure 4‑36: Class 2 Device Recall Cordis S.M.A.R.T. CONTROL /S.M.A.R.T. Vascular Stent System96
Figure 4‑37: Class 2 Device Recall S.M.A.R.T. Nitinol Stent System and the S.M.A.R.T. Control Nitinol Stent System97
Figure 4‑38: Class 2 Device Recall Cordis Precise Nitinol Stent System97
Figure 4‑39: Class 2 Device Recall Formula 418 Renal BalloonExpandable Stent97
Figure 4‑40: Class 2 Device Recall Zilver 635 Biliary Stent97
Figure 4‑41: Class 2 Device Recall Zilver 518 Biliary Stent98
Figure 4‑42: Class 1 Device Recall Atrium98
Figure 4‑43: Class 2 Device Recall Everflex Selfexpanding Peripheral Stent98
Figure 4‑44: Class 2 Device Recall Medtronic Abre98
Figure 4‑45: Class 2 Device Recall Medtronic Abre Venous Selfexpanding Sent System99
Figure 4‑46: Class 2 Device Recall ENROUTE Transcarotid Stent System99
Figure 4‑47: Class 2 Device Recall GORE VIABAHN VBX, BALLOON EXPANDABLE ENDOPROSTHESIS99
Figure 4‑48: Class 2 Device Recall Conquest PTA Balloon Dilatation Catheter100
Figure 4‑49: Class 2 Device Recall Conquest 40 PTA Dilatation Catheter100
Figure 4‑50: Class 2 Device Recall Cordis SABER PTA Balloon Dilation Catheter100
Figure 4‑51: Class 2 Device Recall Cordis POWERFLEX P3, PTA Dilation Catheter101
Figure 4‑52: Class 2 Device Recall Cordis MAXI LD PTA Dilatation Catheter101
Figure 4‑53: Class 2 Device Recall POWERFLEX PRO Percutaneous Transluminal Angioplasty (PTA) Catheter101
Figure 4‑54: Class 1 Device Recall ADVANCE ENFORCER 35 FOCAL FORCE PTA BALLOON CATHETER101
Figure 4‑55: Class 2 Device Recall Medtronic IN.PACT Admiral, Paclitaxelcoated PTA Balloon Catheter102
Figure 4‑56: Class 2 Device Recall Chameleon PTA Balloon Dilation Catheter102
Figure 4‑57: Class 2 Device Recall Boston Scientific ROTAPRO103
Figure 4‑58: Class 2 Device Recall STEALTH 360 GEN2 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM103
Figure 4‑59: Class 2 Device Recall DIAMONDBACK 360 GEN2 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM103
Figure 4‑60: Class 1 Device Recall TurboHawk Plus103
Figure 4‑61: Class 1 Device Recall HawkOne104
Figure 4‑62: Class 2 Device Recall Shockwave Medical Peripheral Intravascular Lithotripsy (IVL) System105
Figure 4‑63: Class 1 Device Recall IntraClude IntraAortic Occlusion Device106
Figure 4‑64: Class 2 Device Recall Intergard Woven Vascular Graft107
Figure 4‑65: Class 2 Device Recall Interavascular SAS/Getinge107
Figure 4‑66: Class 2 Device Recall Hemashield Gold Knitted Bifurcated107
Figure 4‑67: Class 2 Device Recall Atrium ADVANTA VXT Vascular Graft107
Figure 4‑68: Class 2 Device Recall HEMASHIELD MICROVEL Double Velour Knitted Vascular Grafts108
Figure 4‑69: Class 2 Device Recall HEMASHIELD PLATINUM WOVEN/MICROVEL DOUBLE VELOUR VASCULAR GRAFTS108
Figure 4‑70: Class 2 Device Recall HEMASHIELD PLATINUM Woven Double Velour Vascular Graft108
Figure 4‑71: Class 2 Device Recall VASCUTEK/TERUMO109
Figure 4‑72: Class 2 Device Recall Gore Propaten Vascular Graft109
Figure 4‑73: Class 1 Device Recall ENDOLOGIX AFX2 Bifurcated Endograft System110
Figure 4‑74: Class 1 Device Recall ENDOLOGIX AFX/AFX2, Proximal (Aortic) Extension Endograft110
Figure 4‑75: Class 1 Device Recall ENDOLOGIX AFX Endovascular AAA System110
Figure 4‑76: Class 1 Device Recall ENDOLOGIX AFX/AFX2, Limb (Iliac) Extension Endograft110
Figure 4‑77: Class 2 Device Recall Zenith Alpha Abdominal Endovascular Graft111
Figure 4‑78: Class 2 Device Recall Zenith Alpha Abdominal Endovascular Graft111
Figure 4‑79: Class 2 Device Recall Zenith Alpha SpiralZ Endovascular Leg111
Figure 4‑80: Class 2 Device Recall Zenith Alpha Abdominal Endovascular Graft111
Figure 4‑81: Class 2 Device Recall Endurant, Endurant II and Endurant IIs Stent Graft Systems112
Figure 4‑82: Class 2 Device Recall Endurant Stent Graft System112
Figure 4‑83: Class 2 Device Recall Endurant II Stent Graft System112
Figure 4‑84: Class 2 Device Recall Endurant II/IIs Stent Graft System112
Figure 4‑85: Class 2 Device Recall Endurant II/IIs Stent Graft System113
Figure 4‑86: Class 1 Device Recall Valiant Navion Thoracic Stent Graft System113
Figure 4‑87: Class 2 Device Recall EKOS114
Figure 4‑88: Class 2 Device Recall EkoSonic Endovascular Device114
Figure 4‑89: Class 2 Device Recall EKOS Control System114
Figure 4‑90: Class 2 Device Recall AngioJet Ultra Consoles Thrombectomy System114
Figure 4‑91: Class 1 Device Recall ArrowTrerotola PTD115
Figure 4‑92: Class 1 Device Recall ArrowTrerotola Percutaneous Thrombolytic Device115
Figure 4‑93: Class 1 Device Recall ArrowTrerotola OverTheWire PTD Kit Percutaneous Thrombolytic Device: 7FR115
Figure 4‑94: Device Recall AngioJet Ultra 5000 A Console, Boston Scientific116
Figure 4‑95: Class 3 Device Recall Cook117
Figure 4‑96: Class 3 Device Recall Cook Celect Platinum Vena Cava Filter Set117
Figure 4‑97: Class 2 Device Recall SoftVu Omni Flush Angiographic Catheter118
Figure 4‑98: Class 2 Device Recall SEEKER(R) Crossing Support Catheter118
Figure 4‑99: Class 1 Device Recall Imager II 5F Angiographic Catheter118
Figure 4‑100: Class 1 Device Recall SUPER TORQUE MB 5F PIG118
Figure 4‑101: Class 1 Device Recall CrossCath Support Catheter119
Figure 4‑102: Class 2 Device Recall Torcon NB Advantage119
Figure 4‑103: Class 2 Device Recall Amplatz extra Stiff Wire Guide120
Figure 4‑104: Class 2 Device Recall Bentson Wire Guide120
Figure 4‑105: Class 2 Device Recall Cope Mandril Wire Guide120
Figure 4‑106: Class 2 Device Recall Cope Mandril Wire Guide (Nitinol)120
Figure 4‑107: Class 2 Device Recall Coons Interventional Wire Guide121
Figure 4‑108: Class 2 Device Recall Lunderquist Ring Torque Wire Guide121
Figure 4‑109: Class 2 Device Recall Newton Wire Guide121
Figure 4‑110: Class 2 Device Recall Roadrunner PC Hydrophilic Wire Guide121
Figure 4‑111: Class 2 Device Recall Roadrunner PC Wire Guide (Nimble Floppy)122
Figure 4‑112: Class 2 Device Recall Roadrunner PC Wire Guide (The Firm)122
Figure 4‑113: Class 2 Device Recall Cook Roadrunner UniGlide Hydrophilic Wire Guide122
Figure 4‑114: Class 2 Device Recall Cook Roadrunner PC Wire Guide123
Figure 4‑115: Class 2 Device Recall Roadrunner Hydrophilic PC Wire Guide123
Figure 4‑116: Class 2 Device Recall Zurpaz(TM) MEDIUM CURL, ASYMMETRIC CURVE, Steerable Sheath124
Figure 4‑117: Class 2 Device Recall Ultimum HEMOSTASIS INTRODUCER124
Figure 4‑118: Class 2 Device Recall FastCath Trio HEMOSTASIS INTRODUCER124
Figure 4‑119: Class 2 Device Recall FastCath Hemostasis Introducer, HEMOSTASIS INTRODUCER124
Figure 4‑120: Class 2 Device Recall Avanti Catheter Sheath Introducer125
Figure 4‑121: Class 2 Device Recall125
Figure 4‑122: Class 2 Device Recall Flexor CheckFlo Introducer125
Figure 4‑123: Class 1 Device Recall Flexor CheckFlo Introducer126
Figure 4‑124: Class 2 Device Recall Hilal Embolization Microcoil127
Figure 4‑125: Class 2 Device Recall Nester Embolization Microcoil127
Figure 4‑126: Class 2 Device Recall Tornado Embolization Microcoil127
Figure 4‑127: Class 2 Device Recall Terumo AZUR Peripheral Coil System, Detachable 18127
Figure 4‑128: Class 2 Device Recall Terumo AZUR CX Peripheral Coil System, Detachable 35, CX Coil128
Figure 4‑129: Class 2 Device Recall Terumo AZUR CX Peripheral Coil System, Detachable 18, CX Coil128
Figure 4‑130: Class 2 Device Recall OptiCross 35 15 MHz Peripheral Imaging Catheter129
Figure 4‑131: Peripheral Venous Stent System in the Treatment of Iliac Vein Stenosis or Occlusion131
Figure 4‑132: Belgian Trial Investigating the LifeStream Stent in Complex TASC C and D Iliac Lesions (BELSTREAM)131
Figure 4‑133: Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses (XPEDITE)132
Figure 4‑134: An All-Comers Observational Study of the MicroStent™ Peripheral Vascular Stent System in Subjects With Peripheral Arterial Disease (HEAL)132
Figure 4‑135: SOLARIS Peripheral PMCF Trial132
Figure 4‑136: A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femoro-popliteal Artery Disease133
Figure 4‑137: Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access (RADIANCY)133
Figure 4‑138: Stella Supera Siberia134
Figure 4‑139: A Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal Arteries (REGAL)134
Figure 4‑140: Zilver® PTX® V Clinical Study135
Figure 4‑141: In-Stent Restenosis Post-Approval Study135
Figure 4‑142: BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease (VERNACULAR)136
Figure 4‑143: VIVO Clinical Study137
Figure 4‑144: ULTRASCORE™ Focused Force PTA Balloon Angioplasty for CLI Patients With Below the Knee Vessel Disease138
Figure 4‑145: Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA Balloon138
Figure 4‑146: Ranger™ and Ranger™ SL (OTW) DCB in China139
Figure 4‑147: The VaSecure BTK Study139
Figure 4‑148: Comparison of the Ranger™ Paclitaxel-Coated PTA Balloon Catheter and Uncoated PTA Balloons in Femoropopliteal Arteries (RANGER-SFA)140
Figure 4‑149: A Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon. (BIOPACT-RCT)141
Figure 4‑150: Safety and Efficacy of the SurVeil™ Drug-Coated Balloon (TRANSCEND)141
Figure 4‑151: RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty (RANGER II SFA)142
Figure 4‑152: IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA142
Figure 4‑153: Compare I Pilot Study for the Treatment of Subjects With Symptomatic Femoropopliteal Artery Disease143
Figure 4‑154: ILLUMENATE Below-The-Knee (BTK) Arteries: a Post Market Clinical Study (BTK PMS)143
Figure 4‑155: IN.PACT Global Clinical Study144
Figure 4‑156: ILLUMENATE Pivotal Post-Approval Study (PAS)144
Figure 4‑157: BIOLUX P-III BENELUX All-Comers Registry144
Figure 4‑158: Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter (SAFE-DCB)145
Figure 4‑159: Safety and Effectiveness Evaluation of Peripheral Orbital Atherectomy (KAIZEN)146
Figure 4‑160: Jetstream in Treatment of Occlusive Atherosclerotic Lesions in the SFA and/or PPA146
Figure 4‑161: Revascularization of Total or Sub-total Occluded Peripheral Arteries With ByCross® Device. Post Market Clinical Follow-up147
Figure 4‑162: Post-Market Registry of AURYON™ Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease (PATHFINDER-I)147
Figure 4‑163: JET-RANGER Trial - JETStream Atherectomy With Adjunctive Paclitaxel-Coated Balloon Angioplasty vs Plain Old Balloon Angioplasty Followed by Paclitaxel-Coated Balloon148
Figure 4‑164: Pantheris Atherectomy Treatment of In-Stent Restenosis in Lower Extremity Arteries (INSIGHT)148
Figure 4‑165: Safety and Effectiveness Study of Eximo's B-Laser™ Atherectomy Device for PAD Treatment149
Figure 4‑166: Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME II)149
Figure 4‑167: DiRectional AthErectomy + Drug CoAted BaLloon to Treat Long, CalcifIed FemoropopliTeal ArterY Lesions (REALITY)150
Figure 4‑168: Mini S Feasibility Study With Shockwave Medical Mini S Peripheral IVL System151
Figure 4‑169: SOLUTION Trial in China151
Figure 4‑170: Disrupt PAD+ Study With the Shockwave Medical M5+ Peripheral IVL System (Disrupt PAD+)152
Figure 4‑171: Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)152
Figure 4‑172: A Prospective and Retrospective, Multi-Centre, Post-Market, Non-Interventional Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches (PANTHER)153
Figure 4‑173: Retrospective Post-Market Clinical Follow-Up Study of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access153
Figure 4‑174: Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study154
Figure 4‑175: Post-Approval Study of the TREO Abdominal Stent-Graft System (TREO PAS)154
Figure 4‑176: The Merit WRAPSODY™ Endovascular Stent Graft for Treatment of Iliac Artery Occlusive Disease155
Figure 4‑177: Zenith Alpha™ Abdominal Endovascular Graft155
Figure 4‑178: Fenestrated AAA Endovascular Graft Post-Approval Study156
Figure 4‑179: transShield Embolic Protection System Feasibility Study157
Figure 4‑180: Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System158
Figure 4‑181: Preservation of Venous Valvular Function After PMT for Acute DVT (PREFER)158
Figure 4‑182: A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo Aspiration System (STRIDE)159
Figure 4‑183: FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH)159
Figure 4‑184: JETi Peripheral Thrombectomy Registry (JETi)160
Figure 4‑185: Treatment of Low-Risk Submassive Pulmonary Embolism With FlowTriever160
Figure 4‑186: Forceps vs. Snare IVC Filter Removal161
Figure 4‑187: Predictors of Attempted Inferior Vena Cava Filters Retrieval161
Figure 4‑188: Retrievability and Incidence of Complex Retrieval in Celect Versus Denali Filter162
Figure 4‑189: Cook IVC Filter Study (CIVC)162
Figure 4‑190: Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE)163
Figure 4‑191: Evaluation of Safety and Efficacy of the Mynx Control Venous Vascular Closure Device 6F-12F vs Manual Compression (ReliaSeal)164
Figure 4‑192: AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial164
Figure 4‑193: Vascular Closure Device in Transcatheter Aortic Valve Replacement165
Figure 4‑195: Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA)166
Figure 4‑196: (HALT) Embrace Hydrogel Embolic System (HES) Study of Embolization in Peripheral Arterial Bleeds167
Figure 4‑197: Microvascular Plug (MVP) for the Treatment of Pulmonary ArterioVenous Malformations (PAVMs)167
Figure 4‑198: Use of Interlocking Detachable Coils System in Embolization of Peripheral Arterial Embolization168
Figure 4‑199: CATERPILLAR™ Arterial Embolization Device Study (CHRYSALIS)168
Figure 4‑200: LC Bead LUMI for Prostatic Artery Embolization169
Figure 5‑1: Currency Exchange Rate, 2022172
Figure 5‑2: Peripheral Vascular Device Market by Segment, Europe, 2019 – 2029 (€M) (1 of 3)175
Figure 5‑3: Peripheral Vascular Device Market by Segment, Europe, 2019 – 2029 (€M) (2 of 3)176
Figure 5‑4: Peripheral Vascular Device Market by Segment, Europe, 2019 – 2029 (€M) (3 of 3)177
Figure 5‑5: Peripheral Vascular Device Market by Segment, Europe, 2019 – 2029 (US$M) (1 of 3)178
Figure 5‑6: Peripheral Vascular Device Market by Segment, Europe, 2019 – 2029 (US$M) (2 of 3)179
Figure 5‑7: Peripheral Vascular Device Market by Segment, Europe, 2019 – 2029 (US$M) (3 of 3)180
Figure 5‑8: Leading Competitors, Peripheral Vascular Device Market, Europe, 2022 (1 of 4)191
Figure 5‑9: Leading Competitors, Peripheral Vascular Device Market, Europe, 2022 (2 of 4)192
Figure 5‑10: Leading Competitors, Peripheral Vascular Device Market, Europe, 2022 (3 of 4)193
Figure 5‑11: Leading Competitors, Peripheral Vascular Device Market, Europe, 2022 (4 of 4)194
Figure 5‑12: SWOT Analysis, Abbott (1 of 2)213
Figure 5‑13: SWOT Analysis, Abbott (2 of 2)214
Figure 5‑14: SWOT Analysis, Becton Dickinson (1 of 2)215
Figure 5‑15: SWOT Analysis, Becton Dickinson (2 of 2)216
Figure 5‑16: SWOT Analysis, Boston Scientific217
Figure 5‑17: SWOT Analysis, Cardinal Health218
Figure 5‑18: SWOT Analysis, Cardiovascular Systems, Inc.219
Figure 5‑19: SWOT Analysis, Cook Medical220
Figure 5‑20: SWOT Analysis, Medtronic221
Figure 5‑21: SWOT Analysis, Penumbra222
Figure 5‑22: SWOT Analysis, Philips223
Figure 5‑23: SWOT Analysis, Shockwave Medical224
Figure 5‑24: SWOT Analysis, Silk Road Medical225
Figure 5‑25: SWOT Analysis, Terumo (1 of 2)226
Figure 5‑26: SWOT Analysis, Terumo (2 of 2)227
Figure 5‑27: SWOT Analysis, W.L. Gore228
Figure 7‑1: Peripheral Vascular Device Procedures by Segment, Europe, 2019 – 2029 (1 of 3)242
Figure 7‑2: Peripheral Vascular Device Procedures by Segment, Europe, 2019 – 2029 (2 of 3)243
Figure 7‑3: Peripheral Vascular Device Procedures by Segment, Europe, 2019 – 2029 (3 of 3)244
Figure 7‑4: Peripheral Vascular Stent Procedures by Country, Europe, 2019 – 2029247
Figure 7‑5: Arterial Stent Procedures by Device Type, Europe, 2019 – 2029248
Figure 7‑6: Arterial Stent Procedures by Country, Europe, 2019 – 2029249
Figure 7‑7:  Bare-Metal Stent Procedures by Indication, Europe, 2019 – 2029250
Figure 7‑8:  Bare-Metal Stent Procedures by Country, Europe, 2019 – 2029251
Figure 7‑9: Bare-Metal Carotid Stent Procedures by Country, Europe, 2019 – 2029252
Figure 7‑10: Bare-Metal Iliac Stent Procedures by Country, Europe, 2019 – 2029253
Figure 7‑11: Bare-Metal Renal Stent Procedures by Country, Europe, 2019 – 2029254
Figure 7‑12: Bare-Metal Fem-Pop Stent Procedures by Country, Europe, 2019 – 2029255
Figure 7‑13: Bare-Metal Infra-Pop Stent Procedures by Country, Europe, 2019 – 2029256
Figure 7‑14: Covered Stent Procedures by Indication, Europe, 2019 – 2029257
Figure 7‑15: Covered Stent Procedures by Country, Europe, 2019 – 2029258
Figure 7‑16: Iliac Covered Stent Procedures by Country, Europe, 2019 – 2029259
Figure 7‑17: Fem-Pop Covered Stent Procedures by Country, Europe, 2019 – 2029260
Figure 7‑18: AV Access Covered Stent Procedures by Country, Europe, 2019 – 2029261
Figure 7‑19: Drug-Eluting Stent Procedures by Indication, Europe, 2019 – 2029262
Figure 7‑20: Drug-Eluting Stent Procedures by Country, Europe, 2019 – 2029263
Figure 7‑21: SFA Drug-Eluting Stent Procedures by Country, Europe, 2019 – 2029264
Figure 7‑22: Infra-Pop Drug-Eluting Stent Procedures by Country, Europe, 2019 – 2029265
Figure 7‑23: Venous Stent Procedures by Country, Europe, 2019 – 2029267
Figure 7‑24: PTA Balloon Catheter Procedures by Country, Europe, 2019 – 2029269
Figure 7‑25: Drug-Coated Balloon Procedures by Country, Europe, 2019 – 2029271
Figure 7‑26: Atherectomy Device Procedures by Device Type, Europe, 2019 – 2029272
Figure 7‑27: Atherectomy Device Procedures by Country, Europe, 2019 – 2029273
Figure 7‑28: Laser Atherectomy Device Procedures by Country, Europe, 2019 – 2029274
Figure 7‑29: Mechanical Atherectomy Device Procedures by Country, Europe, 2019 – 2029275
Figure 7‑30: Intravascular Lithotripsy Procedures by Device Type, Europe, 2019 – 2029277
Figure 7‑31: Intravascular Lithotripsy Procedures by Country, Europe, 2019 – 2029278
Figure 7‑32: SFA and Iliac Lithotripsy Procedures by Country, Europe, 2019 – 2029279
Figure 7‑33: BTK Lithotripsy Procedures by Country, Europe, 2019 – 2029280
Figure 7‑34: CTO Device Procedures by Device Type, Europe, 2019 – 2029281
Figure 7‑35: CTO Device Procedures by Country, Europe, 2019 – 2029282
Figure 7‑36: Re-Entry CTO Procedures by Country, Europe, 2019 – 2029283
Figure 7‑37: Recanalization CTO Procedures by Country, Europe, 2019 – 2029284
Figure 7‑38: Total Surgical Graft Procedures by Material, Europe, 2019 – 2029286
Figure 7‑39: Total Surgical Graft Procedures by Country, Europe, 2019 – 2029287
Figure 7‑40: Polyester Surgical Graft Procedures by Country, Europe, 2019 – 2029288
Figure 7‑41: ePTFE Surgical Graft Procedures by Country, Europe, 2019 – 2029289
Figure 7‑42: Total Surgical Graft Procedures by Indication, Europe, 2019 – 2029290
Figure 7‑43: Lower-Limb Surgical Graft Procedures by Country, Europe, 2019 – 2029291
Figure 7‑44: Above-the-Knee Surgical Graft Procedures by Country, Europe, 2019 – 2029292
Figure 7‑45: Below-the-Knee Surgical Graft Procedures by Country, Europe, 2019 – 2029293
Figure 7‑46: AV Access Surgical Graft Procedures by Country, Europe, 2019 – 2029294
Figure 7‑47: Aorta Repair Surgical Graft Procedures by Country, Europe, 2019 – 2029295
Figure 7‑48: Abdominal Aortic Aneurysm Surgical Graft Procedures by Country, Europe, 2019 – 2029296
Figure 7‑49: Thoracic Aortic Aneurysm Surgical Graft Procedures by Country, Europe, 2019 – 2029297
Figure 7‑50: Extra-Anatomical Bypass Surgical Graft Procedures by Country, Europe, 2019 – 2029298
Figure 7‑51: Stent Graft Procedures by Device Type, Europe, 2019 – 2029299
Figure 7‑52: Stent Graft Procedures by Country, Europe, 2019 – 2029300
Figure 7‑53: AAA Stent Graft Procedures by Country, Europe, 2019 – 2029301
Figure 7‑54: Fenestrated Stent Graft Procedures by Country, Europe, 2019 – 2029302
Figure 7‑55: TAA Stent Graft Procedures by Country, Europe, 2019 – 2029303
Figure 7‑56: Embolic Protection Device Procedures by Device Type, Europe, 2019 – 2029304
Figure 7‑57: Embolic Protection Device Procedures by Country, Europe, 2019 – 2029305
Figure 7‑58: Carotid EPD Procedures by Country, Europe, 2019 – 2029306
Figure 7‑59: Renal EPD Procedures by Country, Europe, 2019 – 2029307
Figure 7‑60: Lower-Limb EPD Procedures by Country, Europe, 2019 – 2029308
Figure 7‑61: Peripheral Thrombus Management Procedures by Device Type, Europe, 2019 – 2029309
Figure 7‑62: Peripheral Thrombus Management Procedures by Country, Europe, 2019 – 2029310
Figure 7‑63: Traditional Thrombectomy Device Procedures by Country, Europe, 2019 – 2029311
Figure 7‑64: Pharmacomechanical Thrombectomy Device Procedures by Country, Europe, 2019 – 2029312
Figure 7‑65 IVCF Placement Procedures by Device Type, Europe, 2019 – 2029314
Figure 7‑66 IVCF Placement Procedures by Country, Europe, 2019 – 2029315
Figure 7‑67: Retrievable IVCF Procedures by Country, Europe, 2019 – 2029316
Figure 7‑68: Permanent IVCF Procedures by Country, Europe, 2019 – 2029317
Figure 7‑69: Carotid Shunt Procedures by Country, Europe, 2019 – 2029319
Figure 7‑70: Total Vascular Closure Device Procedures by Device Type, Europe, 2019 – 2029321
Figure 7‑71: Total Vascular Closure Device Procedures by Country, Europe, 2019 – 2029322
Figure 7‑72: Small-Bore Invasive VCD Procedures by Country, Europe, 2019 – 2029323
Figure 7‑73: Large-Bore Invasive VCD Procedures by Country, Europe, 2019 – 2029324
Figure 7‑74: Non-Invasive VCD Procedures by Country, Europe, 2019 – 2029325
Figure 7‑75: Total VCD Procedures by Approach, Europe, 2019 – 2029326
Figure 7‑76: Radial VCD Procedures by Country, Europe, 2019 – 2029327
Figure 7‑77: Femoral VCD Procedures by Country, Europe, 2019 – 2029328
Figure 7‑78: Transcatheter Embolization Procedures by Device Type, Europe, 2019 – 2029330
Figure 7‑79: Transcatheter Embolization Procedures by Country, Europe, 2019 – 2029331
Figure 7‑80: Particle Embolization Procedures by Device Type, Europe, 2019 – 2029332
Figure 7‑81: Particle Embolization Procedures by Country, Europe, 2019 – 2029333
Figure 7‑82: PVA Particle Procedures by Country, Europe, 2019 – 2029334
Figure 7‑83: Microsphere Procedures by Country, Europe, 2019 – 2029335
Figure 7‑84: Drug-Eluting Particle Procedures by Country, Europe, 2019 – 2029336
Figure 7‑85: Radioactive Particle Procedures by Country, Europe, 2019 – 2029337
Figure 7‑86: Coil Embolization Procedures by Device Type, Europe, 2019 – 2029338
Figure 7‑87: Coil Embolization Procedures by Country, Europe, 2019 – 2029339
Figure 7‑88: Pushable Coil Procedures by Country, Europe, 2019 – 2029340
Figure 7‑89: Detachable Coil Procedures by Country, Europe, 2019 – 2029341
Figure 7‑90: Liquid Embolics Procedures by Country, Europe, 2019 – 2029342
Figure 7‑91: Plug Embolization Procedures by Country, Europe, 2019 – 2029343
Figure 7‑92: Peripheral IVUS Procedures by Country, Europe, 2019 – 2029345
Figure 8‑1: Peripheral Vascular Stent Market by Segment, Europe, 2019 – 2029 (€M)353
Figure 8‑2: Peripheral Vascular Stent Market by Segment, Europe, 2019 – 2029 (US$M)353
Figure 8‑3: Arterial Stent Market by Device Type, Europe, 2019 – 2029 (€M)356
Figure 8‑4: Arterial Stent Market by Device Type, Europe, 2019 – 2029 (US$M)356
Figure 8‑5: Arterial Stent Market, Europe, 2019 – 2029357
Figure 8‑6: Units Sold by Country, Arterial Stent Market, Europe, 2019 – 2029358
Figure 8‑7: Average Selling Price by Country, Arterial Stent Market, Europe, 2019 – 2029 (€)359
Figure 8‑8: Average Selling Price by Country, Arterial Stent Market, Europe, 2019 – 2029 (US$)360
Figure 8‑9: Market Value by Country, Arterial Stent Market, Europe, 2019 – 2029 (€M)361
Figure 8‑10: Market Value by Country, Arterial Stent Market, Europe, 2019 – 2029 (US$M)362
Figure 8‑11: Bare-Metal Stent Market by Indication, Europe, 2019 – 2029 (€M)364
Figure 8‑12: Bare-Metal Stent Market by Indication, Europe, 2019 – 2029 (US$M)365
Figure 8‑13: Total Bare-Metal Stent Market, Europe, 2019 – 2029365
Figure 8‑14: Units Sold by Country, Total Bare-Metal Stent Market, Europe, 2019 – 2029366
Figure 8‑15: Average Selling Price by Country, Total Bare-Metal Stent Market, Europe, 2019 – 2029 (€)367
Figure 8‑16: Average Selling Price by Country, Total Bare-Metal Stent Market, Europe, 2019 – 2029 (US$)368
Figure 8‑17: Market Value by Country, Total Bare-Metal Stent Market, Europe, 2019 – 2029 (€M)369
Figure 8‑18: Market Value by Country, Total Bare-Metal Stent Market, Europe, 2019 – 2029 (US$M)370
Figure 8‑19: Bare-Metal Carotid Stent Market, Europe, 2019 – 2029371
Figure 8‑20: Units Sold by Country, Bare-Metal Carotid Stent Market, Europe, 2019 – 2029372
Figure 8‑21: Average Selling Price by Country, Bare-Metal Carotid Stent Market, Europe, 2019 – 2029 (€)373
Figure 8‑22: Average Selling Price by Country, Bare-Metal Carotid Stent Market, Europe, 2019 – 2029 (US$)374
Figure 8‑23: Market Value by Country, Bare-Metal Carotid Stent Market, Europe, 2019 – 2029 (€M)375
Figure 8‑24: Market Value by Country, Bare-Metal Carotid Stent Market, Europe, 2019 – 2029 (US$M)376
Figure 8‑25: Bare-Metal Iliac Stent Market, Europe, 2019 – 2029377
Figure 8‑26: Units Sold by Country, Bare-Metal Iliac Stent Market, Europe, 2019 – 2029378
Figure 8‑27: Average Selling Price by Country, Bare-Metal Iliac Stent Market, Europe, 2019 – 2029 (€)379
Figure 8‑28: Average Selling Price by Country, Bare-Metal Iliac Stent Market, Europe, 2019 – 2029 (US$)380
Figure 8‑29: Market Value by Country, Bare-Metal Iliac Stent Market, Europe, 2019 – 2029 (€M)381
Figure 8‑30: Market Value by Country, Bare-Metal Iliac Stent Market, Europe, 2019 – 2029 (US$M)382
Figure 8‑31: Bare-Metal Renal Stent Market, Europe, 2019 – 2029383
Figure 8‑32: Units Sold by Country, Bare-Metal Renal Stent Market, Europe, 2019 – 2029384
Figure 8‑33: Average Selling Price by Country, Bare-Metal Renal Stent Market, Europe, 2019 – 2029 (€)385
Figure 8‑34: Average Selling Price by Country, Bare-Metal Renal Stent Market, Europe, 2019 – 2029 (US$)386
Figure 8‑35: Market Value by Country, Bare-Metal Renal Stent Market, Europe, 2019 – 2029 (€M)387
Figure 8‑36: Market Value by Country, Bare-Metal Renal Stent Market, Europe, 2019 – 2029 (US$M)388
Figure 8‑37: Bare-Metal Fem-Pop Stent Market, Europe, 2019 – 2029389
Figure 8‑38: Units Sold by Country, Bare-Metal Fem-Pop Stent Market, Europe, 2019 – 2029390
Figure 8‑39: Average Selling Price by Country, Bare-Metal Fem-Pop Stent Market, Europe, 2019 – 2029 (€)391
Figure 8‑40: Average Selling Price by Country, Bare-Metal Fem-Pop Stent Market, Europe, 2019 – 2029 (US$)392
Figure 8‑41: Market Value by Country, Bare-Metal Fem-Pop Stent Market, Europe, 2019 – 2029 (€M)393
Figure 8‑42: Market Value by Country, Bare-Metal Fem-Pop Stent Market, Europe, 2019 – 2029 (US$M)394
Figure 8‑43: Bare-Metal Infra-Pop Stent Market, Europe, 2019 – 2029395
Figure 8‑44: Units Sold by Country, Bare-Metal Infra-Pop Stent Market, Europe, 2019 – 2029396
Figure 8‑45: Average Selling Price by Country, Bare-Metal Infra-Pop Stent Market, Europe, 2019 – 2029 (€)397
Figure 8‑46: Average Selling Price by Country, Bare-Metal Infra-Pop Stent Market, Europe, 2019 – 2029 (US$)398
Figure 8‑47: Market Value by Country, Bare-Metal Infra-Pop Stent Market, Europe, 2019 – 2029 (€M)399
Figure 8‑48: Market Value by Country, Bare-Metal Infra-Pop Stent Market, Europe, 2019 – 2029 (US$M)400
Figure 8‑49: Covered Stent Market, Europe, 2019 – 2029401
Figure 8‑50: Units Sold by Country, Covered Stent Market, Europe, 2019 – 2029402
Figure 8‑51: Average Selling Price by Country, Covered Stent Market, Europe, 2019 – 2029 (€)403
Figure 8‑52: Average Selling Price by Country, Covered Stent Market, Europe, 2019 – 2029 (US$)404
Figure 8‑53: Market Value by Country, Covered Stent Market, Europe, 2019 – 2029 (€M)405
Figure 8‑54: Market Value by Country, Covered Stent Market, Europe, 2019 – 2029 (US$M)406
Figure 8‑55: Drug-Eluting Stent Market, Europe, 2019 – 2029408
Figure 8‑56: Units Sold by Country, Drug-Eluting Stent Market, Europe, 2019 – 2029409
Figure 8‑57: Average Selling Price by Country, Drug-Eluting Stent Market, Europe, 2019 – 2029 (€)410
Figure 8‑58: Average Selling Price by Country, Drug-Eluting Stent Market, Europe, 2019 – 2029 (US$)411
Figure 8‑59: Market Value by Country, Drug-Eluting Stent Market, Europe, 2019 – 2029 (€M)412
Figure 8‑60: Market Value by Country, Drug-Eluting Stent Market, Europe, 2019 – 2029 (US$M)413
Figure 8‑61: Venous Stent Market, Europe, 2019 – 2029415
Figure 8‑62: Units Sold by Country, Venous Stent Market, Europe, 2019 – 2029416
Figure 8‑63: Average Selling Price by Country, Venous Stent Market, Europe, 2019 – 2029 (€)417
Figure 8‑64: Average Selling Price by Country, Venous Stent Market, Europe, 2019 – 2029 (US$)418
Figure 8‑65: Market Value by Country, Venous Stent Market, Europe, 2019 – 2029 (€M)419
Figure 8‑66: Market Value by Country, Venous Stent Market, Europe, 2019 – 2029 (US$M)420
Figure 8‑67: Units Sold by Delivery Platform, Bare-Metal Stent Market, Europe, 2019 – 2029421
Figure 8‑68: Units Sold by Country, Self-Expanding Bare-Metal Stent Market, Europe, 2019 – 2029422
Figure 8‑69: Units Sold by Country, Balloon-Expanding Bare-Metal Stent Market, Europe, 2019 – 2029423
Figure 8‑70: Units Sold by Stent Length, Bare-Metal Stent Market, Europe, 2019 – 2029425
Figure 8‑71: Units Sold by Stent Length, Bare-Metal Carotid Stent Market, Europe, 2019 – 2029426
Figure 8‑72: Units Sold by Stent Length, Bare-Metal Iliac Stent Market, Europe, 2019 – 2029427
Figure 8‑73: Units Sold by Stent Length, Bare-Metal Renal Stent Market, Europe, 2019 – 2029428
Figure 8‑74: Units Sold by Stent Length, Bare-Metal Fem-Popliteal Stent Market, Europe,  2019 – 2029429
Figure 8‑75: Units Sold by Delivery Platform, Covered Stent Market, Europe, 2019 – 2029430
Figure 8‑76: Units Sold by Country, Iliac Covered Stent Market, Europe, 2019 – 2029431
Figure 8‑77: Units Sold by Country, Fem-Pop Covered Stent Market, Europe, 2019 – 2029432
Figure 8‑78: Units Sold by Country, AV Access Covered Stent Market, Europe, 2019 – 2029433
Figure 8‑79: Units Sold by Delivery Platform, Drug-Eluting Stent Market, Europe, 2019 – 2029434
Figure 8‑80: Units Sold by Country, SFA Drug-Eluting Stent Market, Europe, 2019 – 2029435
Figure 8‑81: Units Sold by Country, Infra-Pop Drug-Eluting Stent Market, Europe, 2019 – 2029436
Figure 8‑82: Leading Competitors, Peripheral Vascular Stent Market, Europe, 2022445
Figure 9‑1: PTA Balloon Catheter Market by Segment, Europe, 2019 – 2029 (€M)450
Figure 9‑2: PTA Balloon Catheter Market by Segment, Europe, 2019 – 2029 (US$M)451
Figure 9‑3: Total PTA Balloon Catheter Market, Europe, 2019 – 2029453
Figure 9‑4: Units Sold by Country, PTA Balloon Catheter Market, Europe, 2019 – 2029454
Figure 9‑5: Average Selling Price by Country, PTA Balloon Catheter Market, Europe, 2019 – 2029 (€)455
Figure 9‑6: Average Selling Price by Country, PTA Balloon Catheter Market, Europe, 2019 – 2029 (US$)456
Figure 9‑7: Market Value by Country, PTA Balloon Catheter Market, Europe, 2019 – 2029 (€M)457
Figure 9‑8: Market Value by Country, PTA Balloon Catheter Market, Europe, 2019 – 2029 (US$M)458
Figure 9‑9: Standard PTA Balloon Catheter Market, Europe, 2019 – 2029459
Figure 9‑10: Units Sold by Country, Standard PTA Balloon Catheter Market, Europe, 2019 – 2029460
Figure 9‑11: Average Selling Price by Country, Standard PTA Balloon Catheter Market, Europe, 2019 – 2029 (€)461
Figure 9‑12: Average Selling Price by Country, Standard PTA Balloon Catheter Market, Europe, 2019 – 2029 (US$)462
Figure 9‑13: Market Value by Country, Standard PTA Balloon Catheter Market, Europe, 2019 – 2029 (€M)463
Figure 9‑14: Market Value by Country, Standard PTA Balloon Catheter Market, Europe, 2019 – 2029 (US$M)464
Figure 9‑15: High-Pressure PTA Balloon Catheter Market, Europe, 2019 – 2029465
Figure 9‑16: Units Sold by Country, High-Pressure PTA Balloon Catheter Market, Europe, 2019 – 2029466
Figure 9‑17: Average Selling Price by Country, High-Pressure PTA Balloon Catheter Market, Europe, 2019 – 2029 (€)467
Figure 9‑18: Average Selling Price by Country, High-Pressure PTA Balloon Catheter Market, Europe, 2019 – 2029 (US$)468
Figure 9‑19: Market Value by Country, High-Pressure PTA Balloon Catheter Market, Europe, 2019 – 2029 (€M)469
Figure 9‑20: Market Value by Country, High-Pressure PTA Balloon Catheter Market, Europe, 2019 – 2029 (US$M)470
Figure 9‑21: Large PTA Balloon Catheter Market, Europe, 2019 – 2029471
Figure 9‑22: Units Sold by Country, Large PTA Balloon Catheter Market, Europe, 2019 – 2029472
Figure 9‑23: Average Selling Price by Country, Large PTA Balloon Catheter Market, Europe, 2019 – 2029 (€)473
Figure 9‑24: Average Selling Price by Country, Large PTA Balloon Catheter Market, Europe, 2019 – 2029 (US$)474
Figure 9‑25: Market Value by Country, Large PTA Balloon Catheter Market, Europe, 2019 – 2029 (€M)475
Figure 9‑26: Market Value by Country, Large PTA Balloon Catheter Market, Europe, 2019 – 2029 (US$M)476
Figure 9‑27: Small PTA Balloon Catheter Market, Europe, 2019 – 2029477
Figure 9‑28: Units Sold by Country, Small PTA Balloon Catheter Market, Europe, 2019 – 2029478
Figure 9‑29: Average Selling Price by Country, Small PTA Balloon Catheter Market, Europe, 2019 – 2029 (€)479
Figure 9‑30: Average Selling Price by Country, Small PTA Balloon Catheter Market, Europe, 2019 – 2029 (US$)480
Figure 9‑31: Market Value by Country, Small PTA Balloon Catheter Market, Europe, 2019 – 2029 (€M)481
Figure 9‑32: Market Value by Country, Small PTA Balloon Catheter Market, Europe, 2019 – 2029 (US$M)482
Figure 9‑33: Specialty PTA Balloon Catheter Market, Europe, 2019 – 2029483
Figure 9‑34: Units Sold by Country, Specialty PTA Balloon Catheter Market, Europe, 2019 – 2029484
Figure 9‑35: Average Selling Price by Country, Specialty PTA Balloon Catheter Market, Europe, 2019 – 2029 (€)485
Figure 9‑36: Average Selling Price by Country, Specialty PTA Balloon Catheter Market, Europe, 2019 – 2029 (US$)486
Figure 9‑37: Market Value by Country, Specialty PTA Balloon Catheter Market, Europe, 2019 – 2029 (€M)487
Figure 9‑38: Market Value by Country, Specialty PTA Balloon Catheter Market, Europe, 2019 – 2029 (US$M)488
Figure 9‑39: Leading Competitors by Country, PTA Balloon Catheter Market, Europe, 2022494
Figure 10‑1: Drug-Coated Balloon Market, Europe, 2019 – 2029499
Figure 10‑2: Units Sold by Country, Drug-Coated Balloon Market, Europe, 2019 – 2029501
Figure 10‑3: Average Selling Price by Country, Drug-Coated Balloon Market, Europe, 2019 – 2029 (€)502
Figure 10‑4: Average Selling Price by Country, Drug-Coated Balloon Market, Europe, 2019 – 2029 (US$)503
Figure 10‑5: Market Value by Country, Drug-Coated Balloon Market, Europe, 2019 – 2029 (€M)504
Figure 10‑6: Market Value by Country, Drug-Coated Balloon Market, Europe, 2019 – 2029 (US$M)505
Figure 10‑7: Leading Competitors, Drug-Coated Balloon Market, Europe, 2022510
Figure 11‑1: Atherectomy Device Market by Segment, Europe, 2019 – 2029 (€M)515
Figure 11‑2: Atherectomy Device Market by Segment, Europe, 2019 – 2029 (US$M)515
Figure 11‑3: Total Atherectomy Device Market, Europe, 2019 – 2029518
Figure 11‑4: Units Sold by Country, Atherectomy Device Market, Europe, 2019 – 2029519
Figure 11‑5: Average Selling Price by Country, Atherectomy Device Market, Europe, 2019 – 2029 (€)520
Figure 11‑6: Average Selling Price by Country, Atherectomy Device Market, Europe, 2019 – 2029 (US$)521
Figure 11‑7: Market Value by Country, Atherectomy Device Market, Europe, 2019 – 2029 (€M)522
Figure 11‑8: Market Value by Country, Atherectomy Device Market, Europe, 2019 – 2029 (US$M)523
Figure 11‑9: Laser Atherectomy Device Market, Europe, 2019 – 2029524
Figure 11‑10: Units Sold by Country, Laser Atherectomy Device Market, Europe, 2019 – 2029525
Figure 11‑11: Average Selling Price by Country, Laser Atherectomy Device Market, Europe, 2019 – 2029 (€)526
Figure 11‑12: Average Selling Price by Country, Laser Atherectomy Device Market, Europe, 2019 – 2029 (US$)527
Figure 11‑13: Market Value by Country, Laser Atherectomy Device Market, Europe, 2019 – 2029 (€M)528
Figure 11‑14: Market Value by Country, Laser Atherectomy Device Market, Europe, 2019 – 2029 (US$M)529
Figure 11‑15: Mechanical Atherectomy Device Market, Europe, 2019 – 2029530
Figure 11‑16: Units Sold by Country, Mechanical Atherectomy Device Market, Europe, 2019 – 2029531
Figure 11‑17: Average Selling Price by Country, Mechanical Atherectomy Device Market, Europe, 2019 – 2029 (€)532
Figure 11‑18: Average Selling Price by Country, Mechanical Atherectomy Device Market, Europe, 2019 – 2029 (US$)533
Figure 11‑19: Market Value by Country, Mechanical Atherectomy Device Market, Europe, 2019 – 2029 (€M)534
Figure 11‑20: Market Value by Country, Mechanical Atherectomy Device Market, Europe, 2019 – 2029 (US$M)535
Figure 11‑21: Leading Competitors, Atherectomy Device Market, Europe, 2022541
Figure 12‑1: Intravascular Lithotripsy Market, Europe, 2019 – 2029545
Figure 12‑2: Units Sold by Country, Intravascular Lithotripsy Market, Europe, 2019 – 2029547
Figure 12‑3: Average Selling Price by Country, Intravascular Lithotripsy Market, Europe, 2019 – 2029 (€)548
Figure 12‑4: Average Selling Price by Country, Intravascular Lithotripsy Market, Europe, 2019 – 2029 (US$)549
Figure 12‑5: Market Value by Country, Intravascular Lithotripsy Market, Europe, 2019 – 2029 (€M)550
Figure 12‑6: Market Value by Country, Intravascular Lithotripsy Market, Europe, 2019 – 2029 (US$M)551
Figure 12‑7: Leading Competitors, Intravascular Lithotripsy Market, Europe, 2022554
Figure 13‑1: CTO Device Market by Segment, Europe, 2019 – 2029 (€M)556
Figure 13‑2: CTO Device Market by Segment, Europe, 2019 – 2029 (US$M)557
Figure 13‑3: Total CTO Device Market, Europe, 2019 – 2029559
Figure 13‑4: Units Sold by Country, CTO Device Market, Europe, 2019 – 2029560
Figure 13‑5: Average Selling Price by Country, CTO Device Market, Europe, 2019 – 2029 (€)561
Figure 13‑6: Average Selling Price by Country, CTO Device Market, Europe, 2019 – 2029 (US$)562
Figure 13‑7: Market Value by Country, CTO Device Market, Europe, 2019 – 2029 (€M)563
Figure 13‑8: Market Value by Country, CTO Device Market, Europe, 2019 – 2029 (US$M)564
Figure 13‑9: Re-Entry Device Market, Europe, 2019 – 2029565
Figure 13‑10: Units Sold by Country, Re-Entry Device Market, Europe, 2019 – 2029566
Figure 13‑11: Average Selling Price by Country, Re-Entry Device Market, Europe, 2019 – 2029 (€)567
Figure 13‑12: Average Selling Price by Country, Re-Entry Device Market, Europe, 2019 – 2029 (US$)568
Figure 13‑13: Market Value by Country, Re-Entry Device Market, Europe, 2019 – 2029 (€M)569
Figure 13‑14: Market Value by Country, Re-Entry Device Market, Europe, 2019 – 2029 (US$M)570
Figure 13‑15: Recanalization Device Market, Europe, 2019 – 2029571
Figure 13‑16: Units Sold by Country, Recanalization Device Market, Europe, 2019 – 2029572
Figure 13‑17: Average Selling Price by Country, Recanalization Device Market, Europe, 2019 – 2029 (€)573
Figure 13‑18: Average Selling Price by Country, Recanalization Device Market, Europe, 2019 – 2029 (US$)574
Figure 13‑19: Market Value by Country, Recanalization Device Market, Europe, 2019 – 2029 (€M)575
Figure 13‑20: Market Value by Country, Recanalization Device Market, Europe, 2019 – 2029 (US$M)576
Figure 13‑21: Leading Competitors, CTO Device Market, Europe, 2022580
Figure 14‑1: Surgical Graft Market by Segment, Europe, 2019 – 2029 (€M)583
Figure 14‑2: Surgical Graft Market by Segment, Europe, 2019 – 2029 (US$M)584
Figure 14‑3: Total Lower-Limb Surgical Graft Market by Segment, Europe, 2019 – 2029 (€M)587
Figure 14‑4: Lower-Limb Surgical Graft Market by Segment, Europe, 2019 – 2029 (US$M)588
Figure 14‑5: Total Lower-Limb Surgical Graft Market, Europe, 2019 – 2029588
Figure 14‑6: Units Sold by Country, Total Lower-Limb Surgical Graft Market, Europe, 2019 – 2029589
Figure 14‑7: Average Selling Price by Country, Total Lower-Limb Surgical Graft Market, Europe, 2019 – 2029 (€)590
Figure 14‑8: Average Selling Price by Country, Total Lower-Limb Surgical Graft Market, Europe, 2019 – 2029 (US$)591
Figure 14‑9: Market Value by Country, Total Lower-Limb Surgical Graft Market, Europe, 2019 – 2029 (€M)592
Figure 14‑10: Market Value by Country, Total Lower-Limb Surgical Graft Market, Europe, 2019 – 2029 (US$M)593
Figure 14‑11: Above-the-Knee Surgical Graft Market, Europe, 2019 – 2029594
Figure 14‑12: Units Sold by Country, Above-the-Knee Surgical Graft Market, Europe, 2019 – 2029595
Figure 14‑13: Average Selling Price by Country, Above-the-Knee Surgical Graft Market, Europe, 2019 – 2029 (€)596
Figure 14‑14: Average Selling Price by Country, Above-the-Knee Surgical Graft Market, Europe, 2019 – 2029 (US$)597
Figure 14‑15: Market Value by Country, Above-the-Knee Surgical Graft Market, Europe, 2019 – 2029 (€M)598
Figure 14‑16: Market Value by Country, Above-the-Knee Surgical Graft Market, Europe, 2019 – 2029 (US$M)599
Figure 14‑17: Below-the-Knee Surgical Graft Market, Europe, 2019 – 2029600
Figure 14‑18: Units Sold by Country, Below-the-Knee Surgical Graft Market, Europe, 2019 – 2029601
Figure 14‑19: Average Selling Price by Country, Below-the-Knee Surgical Graft Market, Europe, 2019 – 2029 (€)602
Figure 14‑20: Average Selling Price by Country, Below-the-Knee Surgical Graft Market, Europe, 2019 – 2029 (US$)603
Figure 14‑21: Market Value by Country, Below-the-Knee Surgical Graft Market, Europe, 2019 – 2029 (€M)604
Figure 14‑22: Market Value by Country, Below-the-Knee Surgical Graft Market, Europe, 2019 – 2029 (US$M)605
Figure 14‑23: AV Access Surgical Graft Market, Europe, 2019 – 2029606
Figure 14‑24: Units Sold by Country, AV Access Surgical Graft Market, Europe, 2019 – 2029607
Figure 14‑25: Average Selling Price by Country, AV Access Surgical Graft Market, Europe, 2019 – 2029 (€)608
Figure 14‑26: Average Selling Price by Country, AV Access Surgical Graft Market, Europe, 2019 – 2029 (US$)609
Figure 14‑27: Market Value by Country, AV Access Surgical Graft Market, Europe, 2019 – 2029 (€M)610
Figure 14‑28: Market Value by Country, AV Access Surgical Graft Market, Europe, 2019 – 2029 (US$M)611
Figure 14‑29: Total Aorta Repair Surgical Graft Market by Segment, Europe, 2019 – 2029 (€M)612
Figure 14‑30: Aorta Repair Surgical Graft Market by Segment, Europe, 2019 – 2029 (US$M)613
Figure 14‑31: Total Aorta Repair Surgical Graft Market, Europe, 2019 – 2029614
Figure 14‑32: Units Sold by Country, Total Aorta Repair Surgical Graft Market, Europe, 2019 – 2029615
Figure 14‑33: Average Selling Price by Country, Total Aorta Repair Surgical Graft Market, Europe, 2019 – 2029 (€)616
Figure 14‑34: Average Selling Price by Country, Total Aorta Repair Surgical Graft Market, Europe, 2019 – 2029 (US$)617
Figure 14‑35: Market Value by Country, Total Aorta Repair Surgical Graft Market, Europe, 2019 – 2029 (€M)618
Figure 14‑36: Market Value by Country, Total Aorta Repair Surgical Graft Market, Europe, 2019 – 2029 (US$M)619
Figure 14‑37: Abdominal Aortic Aneurysm Surgical Graft Market, Europe, 2019 – 2029620
Figure 14‑38: Units Sold by Country, Abdominal Aortic Aneurysm Surgical Graft Market, Europe, 2019 – 2029621
Figure 14‑39: Average Selling Price by Country, Abdominal Aortic Aneurysm Surgical Graft Market, Europe, 2019 – 2029 (€)622
Figure 14‑40: Average Selling Price by Country, Abdominal Aortic Aneurysm Surgical Graft Market, Europe, 2019 – 2029 (US$)623
Figure 14‑41: Market Value by Country, Abdominal Aortic Aneurysm Surgical Graft Market, Europe, 2019 – 2029 (€M)624
Figure 14‑42: Market Value by Country, Abdominal Aortic Aneurysm Surgical Graft Market, Europe, 2019 – 2029 (US$M)625
Figure 14‑43: Thoracic Aortic Aneurysm Surgical Graft Market, Europe, 2019 – 2029626
Figure 14‑44: Units Sold by Country, Thoracic Aortic Aneurysm Surgical Graft Market, Europe, 2019 – 2029627
Figure 14‑45: Average Selling Price by Country, Thoracic Aortic Aneurysm Surgical Graft Market, Europe, 2019 – 2029 (€)628
Figure 14‑46: Average Selling Price by Country, Thoracic Aortic Aneurysm Surgical Graft Market, Europe, 2019 – 2029 (US$)629
Figure 14‑47: Market Value by Country, Thoracic Aortic Aneurysm Surgical Graft Market, Europe, 2019 – 2029 (€M)630
Figure 14‑48: Market Value by Country, Thoracic Aortic Aneurysm Surgical Graft Market, Europe, 2019 – 2029 (US$M)631
Figure 14‑49: Extra-Anatomical Bypass Surgical Graft Market, Europe, 2019 – 2029632
Figure 14‑50: Units Sold by Country, Extra-Anatomical Bypass Surgical Graft Market, Europe, 2019 – 2029633
Figure 14‑51: Average Selling Price by Country, Extra-Anatomical Bypass Surgical Graft Market, Europe, 2019 – 2029 (€)634
Figure 14‑52: Average Selling Price by Country, Extra-Anatomical Bypass Surgical Graft Market, Europe, 2019 – 2029 (US$)635
Figure 14‑53: Market Value by Country, Extra-Anatomical Bypass Surgical Graft Market, Europe, 2019 – 2029 (€M)636
Figure 14‑54: Market Value by Country, Extra-Anatomical Bypass Surgical Graft Market, Europe, 2019 – 2029 (US$M)637
Figure 14‑55: Units Sold by Material, Surgical Graft Market, Europe, 2019 – 2029638
Figure 14‑56: Units Sold by Country, Polyester Surgical Graft Market, Europe, 2019 – 2029639
Figure 14‑57: Units Sold by Country, ePTFE Surgical Graft Market, Europe, 2019 – 2029640
Figure 14‑58: Leading Competitors, Surgical Graft Market, Europe, 2022645
Figure 15‑1: Stent Graft Market by Segment, Europe, 2019 – 2029 (€M)648
Figure 15‑2: Stent Graft Market by Segment, Europe, 2019 – 2029 (US$M)649
Figure 15‑3: Total Stent Graft Market, Europe, 2019 – 2029652
Figure 15‑4: Units Sold by Country, Stent Graft Market, Europe, 2019 – 2029653
Figure 15‑5: Average Selling Price by Country, Stent Graft Market, Europe, 2019 – 2029 (€)654
Figure 15‑6: Average Selling Price by Country, Stent Graft Market, Europe, 2019 – 2029 (US$)655
Figure 15‑7: Market Value by Country, Stent Graft Market, Europe, 2019 – 2029 (€M)656
Figure 15‑8: Market Value by Country, Stent Graft Market, Europe, 2019 – 2029 (US$M)657
Figure 15‑9: AAA Stent Graft Market, Europe, 2019 – 2029658
Figure 15‑10: Units Sold by Country, AAA Stent Graft Market, Europe, 2019 – 2029659
Figure 15‑11: Average Selling Price by Country, AAA Stent Graft Market, Europe, 2019 – 2029 (€)660
Figure 15‑12: Average Selling Price by Country, AAA Stent Graft Market, Europe, 2019 – 2029 (US$)661
Figure 15‑13: Market Value by Country, AAA Stent Graft Market, Europe, 2019 – 2029 (€M)662
Figure 15‑14: Market Value by Country, AAA Stent Graft Market, Europe, 2019 – 2029 (US$M)663
Figure 15‑15: TAA Stent Graft Market, Europe, 2019 – 2029664
Figure 15‑16: Units Sold by Country, TAA Stent Graft Market, Europe, 2019 – 2029665
Figure 15‑17: Average Selling Price by Country, TAA Stent Graft Market, Europe, 2019 – 2029 (€)666
Figure 15‑18: Average Selling Price by Country, TAA Stent Graft Market, Europe, 2019 – 2029 (US$)667
Figure 15‑19: Market Value by Country, TAA Stent Graft Market, Europe, 2019 – 2029 (€M)668
Figure 15‑20: Market Value by Country, TAA Stent Graft Market, Europe, 2019 – 2029 (US$M)669
Figure 15‑21: Fenestrated Stent Graft Market, Europe, 2019 – 2029671
Figure 15‑22: Units Sold by Country, Fenestrated Stent Graft Market, Europe, 2019 – 2029672
Figure 15‑23: Average Selling Price by Country, Fenestrated Stent Graft Market, Europe, 2019 – 2029 (€)673
Figure 15‑24: Average Selling Price by Country, Fenestrated Stent Graft Market, Europe, 2019 – 2029 (US$)674
Figure 15‑25: Market Value by Country, Fenestrated Stent Graft Market, Europe, 2019 – 2029 (€M)675
Figure 15‑26: Market Value by Country, Fenestrated Stent Graft Market, Europe, 2019 – 2029 (US$M)676
Figure 15‑27: Leading Competitors, Stent Graft Market, Europe, 2022682
Figure 16‑1: Embolic Protection Device Market by Segment, Europe, 2019 – 2029 (€M)686
Figure 16‑2: Embolic Protection Device Market by Segment, Europe, 2019 – 2029 (US$M)687
Figure 16‑3: Total Embolic Protection Device Market, Europe, 2019 – 2029689
Figure 16‑4: Units Sold by Country, Embolic Protection Device Market, Europe, 2019 – 2029690
Figure 16‑5: Average Selling Price by Country, Embolic Protection Device Market, Europe, 2019 – 2029 (€)691
Figure 16‑6: Average Selling Price by Country, Embolic Protection Device Market, Europe, 2019 – 2029 (US$)692
Figure 16‑7: Market Value by Country, Embolic Protection Device Market, Europe, 2019 – 2029 (€M)693
Figure 16‑8: Market Value by Country, Embolic Protection Device Market, Europe, 2019 – 2029 (US$M)694
Figure 16‑9: Carotid Embolic Protection Device Market, Europe, 2019 – 2029695
Figure 16‑10: Units Sold by Country, Carotid Embolic Protection Device Market, Europe, 2019 – 2029696
Figure 16‑11: Average Selling Price by Country, Carotid Embolic Protection Device Market, Europe, 2019 – 2029 (€)697
Figure 16‑12: Average Selling Price by Country, Carotid Embolic Protection Device Market, Europe, 2019 – 2029 (US$)698
Figure 16‑13: Market Value by Country, Carotid Embolic Protection Device Market, Europe, 2019 – 2029 (€M)699
Figure 16‑14: Market Value by Country, Carotid Embolic Protection Device Market, Europe, 2019 – 2029 (US$M)700
Figure 16‑15: Renal Embolic Protection Device Market, Europe, 2019 – 2029701
Figure 16‑16: Units Sold by Country, Renal Embolic Protection Device Market, Europe, 2019 – 2029702
Figure 16‑17: Average Selling Price by Country, Renal Embolic Protection Device Market, Europe, 2019 – 2029 (€)703
Figure 16‑18: Average Selling Price by Country, Renal Embolic Protection Device Market, Europe, 2019 – 2029 (US$)704
Figure 16‑19: Market Value by Country, Renal Embolic Protection Device Market, Europe, 2019 – 2029 (€M)705
Figure 16‑20: Market Value by Country, Renal Embolic Protection Device Market, Europe, 2019 – 2029 (US$M)706
Figure 16‑21: Lower-Limb Embolic Protection Device Market, Europe, 2019 – 2029707
Figure 16‑22: Units Sold by Country, Lower-Limb Embolic Protection Device Market, Europe, 2019 – 2029708
Figure 16‑23: Average Selling Price by Country, Lower-Limb Embolic Protection Device Market, Europe, 2019 – 2029 (€)709
Figure 16‑24: Average Selling Price by Country, Lower-Limb Embolic Protection Device Market, Europe, 2019 – 2029 (US$)710
Figure 16‑25: Market Value by Country, Lower-Limb Embolic Protection Device Market, Europe, 2019 – 2029 (€M)711
Figure 16‑26: Market Value by Country, Lower-Limb Embolic Protection Device Market, Europe, 2019 – 2029 (US$M)712
Figure 16‑27: Leading Competitors, Embolic Protection Device Market, Europe, 2022716
Figure 17‑1: Peripheral Thrombus Management Market by Segment, Europe, 2019 – 2029 (€M)721
Figure 17‑2: Peripheral Thrombus Management Market by Segment, Europe, 2019 – 2029 (US$M)721
Figure 17‑3: Total Peripheral Thrombus Management Market, Europe, 2019 – 2029723
Figure 17‑4: Units Sold by Country, Peripheral Thrombus Management Market, Europe, 2019 – 2029724
Figure 17‑5: Average Selling Price by Country, Peripheral Thrombus Management Market, Europe, 2019 – 2029 (€)725
Figure 17‑6: Average Selling Price by Country, Peripheral Thrombus Management Market, Europe, 2019 – 2029 (US$)726
Figure 17‑7: Market Value by Country, Peripheral Thrombus Management Market, Europe, 2019 – 2029 (€M)727
Figure 17‑8: Market Value by Country, Peripheral Thrombus Management Market, Europe, 2019 – 2029 (US$M)728
Figure 17‑9: Traditional Thrombectomy Device Market, Europe, 2019 – 2029729
Figure 17‑10: Units Sold by Country, Traditional Thrombectomy Device Market, Europe, 2019 – 2029730
Figure 17‑11: Average Selling Price by Country, Traditional Thrombectomy Device Market, Europe, 2019 – 2029 (€)731
Figure 17‑12: Average Selling Price by Country, Traditional Thrombectomy Device Market, Europe, 2019 – 2029 (US$)732
Figure 17‑13: Market Value by Country, Traditional Thrombectomy Device Market, Europe, 2019 – 2029 (€M)733
Figure 17‑14: Market Value by Country, Traditional Thrombectomy Device Market, Europe, 2019 – 2029 (US$M)734
Figure 17‑15: Pharmacomechanical Thrombectomy Device Market, Europe, 2019 – 2029736
Figure 17‑16: Units Sold by Country, Pharmacomechanical Thrombectomy Device Market, Europe, 2019 – 2029737
Figure 17‑17: Average Selling Price by Country, Pharmacomechanical Thrombectomy Device Market, Europe, 2019 – 2029 (€)738
Figure 17‑18: Average Selling Price by Country, Pharmacomechanical Thrombectomy Device Market, Europe, 2019 – 2029 (US$)739
Figure 17‑19: Market Value by Country, Pharmacomechanical Thrombectomy Device Market, Europe, 2019 – 2029 (€M)740
Figure 17‑20: Market Value by Country, Pharmacomechanical Thrombectomy Device Market, Europe, 2019 – 2029 (US$M)741
Figure 17‑21: Leading Competitors, Peripheral Thrombus Management Market, Europe, 2022745
Figure 18‑1: Inferior Vena Cava Filter Market by Segment, Europe, 2019 – 2029 (€M)749
Figure 18‑2: Inferior Vena Cava Filter Market by Segment, Europe, 2019 – 2029 (US$M)750
Figure 18‑3: Total Inferior Vena Cava Filter Market, Europe, 2019 – 2029753
Figure 18‑4: Units Sold by Country, Inferior Vena Cava Filter Market, Europe, 2019 – 2029754
Figure 18‑5: Average Selling Price by Country, Inferior Vena Cava Filter Market, Europe, 2019 – 2029 (€)755
Figure 18‑6: Average Selling Price by Country, Inferior Vena Cava Filter Market, Europe, 2019 – 2029 (US$)756
Figure 18‑7: Market Value by Country, Inferior Vena Cava Filter Market, Europe, 2019 – 2029 (€M)757
Figure 18‑8: Market Value by Country, Inferior Vena Cava Filter Market, Europe, 2019 – 2029 (US$M)758
Figure 18‑9: Retrievable IVCF Market, Europe, 2019 – 2029759
Figure 18‑10: Units Sold by Country, Retrievable IVCF Market, Europe, 2019 – 2029760
Figure 18‑11: Average Selling Price by Country, Retrievable IVCF Market, Europe, 2019 – 2029 (€)761
Figure 18‑12: Average Selling Price by Country, Retrievable IVCF Market, Europe, 2019 – 2029 (US$)762
Figure 18‑13: Market Value by Country, Retrievable IVCF Market, Europe, 2019 – 2029 (€M)763
Figure 18‑14: Market Value by Country, Retrievable IVCF Market, Europe, 2019 – 2029 (US$M)764
Figure 18‑15: Permanent IVCF Market, Europe, 2019 – 2029765
Figure 18‑16: Units Sold by Country, Permanent IVCF Market, Europe, 2019 – 2029766
Figure 18‑17: Average Selling Price by Country, Permanent IVCF Market, Europe, 2019 – 2029 (€)767
Figure 18‑18: Average Selling Price by Country, Permanent IVCF Market, Europe, 2019 – 2029 (US$)768
Figure 18‑19: Market Value by Country, Permanent IVCF Market, Europe, 2019 – 2029 (€M)769
Figure 18‑20: Market Value by Country, Permanent IVCF Market, Europe, 2019 – 2029 (US$M)770
Figure 18‑21: Leading Competitors, Inferior Vena Cava Filter Market, Europe, 2022775
Figure 19‑1: Carotid Shunt Market, Europe, 2019 – 2029778
Figure 19‑2: Units Sold by Country, Carotid Shunt Market, Europe, 2019 – 2029780
Figure 19‑3: Average Selling Price by Country, Carotid Shunt Market, Europe, 2019 – 2029 (€)781
Figure 19‑4: Average Selling Price by Country, Carotid Shunt Market, Europe, 2019 – 2029 (US$)782
Figure 19‑5: Market Value by Country, Carotid Shunt Market, Europe, 2019 – 2029 (€M)783
Figure 19‑6: Market Value by Country, Carotid Shunt Market, Europe, 2019 – 2029 (US$M)784
Figure 19‑7: Leading Competitors, Carotid Shunt Market, Europe, 2022787
Figure 20‑1: Diagnostic and Interventional Catheter Market by Segment, Europe, 2019 – 2029 (€M)790
Figure 20‑2: Diagnostic and Interventional Catheter Market by Segment, Europe,  2019 – 2029 (US$M)791
Figure 20‑3: Total Diagnostic and Interventional Catheter Market, Europe, 2019 – 2029793
Figure 20‑4: Units Sold by Country, Diagnostic and Interventional Catheter Market, Europe, 2019 – 2029794
Figure 20‑5: Average Selling Price by Country, Diagnostic and Interventional Catheter Market, Europe, 2019 – 2029 (€)795
Figure 20‑6: Average Selling Price by Country, Diagnostic and Interventional Catheter Market, Europe, 2019 – 2029 (US$)796
Figure 20‑7: Market Value by Country, Diagnostic and Interventional Catheter Market, Europe, 2019 – 2029 (€M)797
Figure 20‑8: Market Value by Country, Diagnostic and Interventional Catheter Market, Europe, 2019 – 2029 (US$M)798
Figure 20‑9: Total Diagnostic Catheter Market by Segment, Europe, 2019 – 2029 (€M)799
Figure 20‑10: Diagnostic Catheter Market by Segment, Europe, 2019 – 2029 (US$M)800
Figure 20‑11: Total Diagnostic Catheter Market, Europe, 2019 – 2029800
Figure 20‑12: Units Sold by Country, Total Diagnostic Catheter Market, Europe, 2019 – 2029801
Figure 20‑13: Average Selling Price by Country, Total Diagnostic Catheter Market, Europe, 2019 – 2029 (€)802
Figure 20‑14: Average Selling Price by Country, Total Diagnostic Catheter Market, Europe, 2019 – 2029 (US$)803
Figure 20‑15: Market Value by Country, Total Diagnostic Catheter Market, Europe, 2019 – 2029 (€M)804
Figure 20‑16: Market Value by Country, Total Diagnostic Catheter Market, Europe, 2019 – 2029 (US$M)805
Figure 20‑17: Standard Diagnostic Catheter Market, Europe, 2019 – 2029806
Figure 20‑18: Units Sold by Country, Standard Diagnostic Catheter Market, Europe, 2019 – 2029807
Figure 20‑19: Average Selling Price by Country, Standard Diagnostic Catheter Market, Europe, 2019 – 2029 (€)808
Figure 20‑20: Average Selling Price by Country, Standard Diagnostic Catheter Market, Europe, 2019 – 2029 (US$)809
Figure 20‑21: Market Value by Country, Standard Diagnostic Catheter Market, Europe, 2019 – 2029 (€M)810
Figure 20‑22: Market Value by Country, Standard Diagnostic Catheter Market, Europe, 2019 – 2029 (US$M)811
Figure 20‑23: Hydrophilic Diagnostic Catheter Market, Europe, 2019 – 2029812
Figure 20‑24: Units Sold by Country, Hydrophilic Diagnostic Catheter Market, Europe, 2019 – 2029813
Figure 20‑25: Average Selling Price by Country, Hydrophilic Diagnostic Catheter Market, Europe, 2019 – 2029 (€)814
Figure 20‑26: Average Selling Price by Country, Hydrophilic Diagnostic Catheter Market, Europe, 2019 – 2029 (US$)815
Figure 20‑27: Market Value by Country, Hydrophilic Diagnostic Catheter Market, Europe, 2019 – 2029 (€M)816
Figure 20‑28: Market Value by Country, Hydrophilic Diagnostic Catheter Market, Europe, 2019 – 2029 (US$M)817
Figure 20‑29: Support Catheter Market, Europe, 2019 – 2029818
Figure 20‑30: Units Sold by Country, Support Catheter Market, Europe, 2019 – 2029819
Figure 20‑31: Average Selling Price by Country, Support Catheter Market, Europe, 2019 – 2029 (€)820
Figure 20‑32: Average Selling Price by Country, Support Catheter Market, Europe, 2019 – 2029 (US$)821
Figure 20‑33: Market Value by Country, Support Catheter Market, Europe, 2019 – 2029 (€M)822
Figure 20‑34: Market Value by Country, Support Catheter Market, Europe, 2019 – 2029 (US$M)823
Figure 20‑35: Leading Competitors, Diagnostic and Interventional Catheter Market, Europe, 2022828
Figure 21‑1: Diagnostic and Interventional Guidewire Market by Segment, Europe,  2019 – 2029 (€M)831
Figure 21‑2: Diagnostic and Interventional Guidewire Market by Segment, Europe,  2019 – 2029 (US$M)832
Figure 21‑3: Total Diagnostic and Interventional Guidewire Market, Europe, 2019 – 2029834
Figure 21‑4: Units Sold by Country, Diagnostic and Interventional Guidewire Market, Europe, 2019 – 2029835
Figure 21‑5: Average Selling Price by Country, Diagnostic and Interventional Guidewire Market, Europe, 2019 – 2029 (€)836
Figure 21‑6: Average Selling Price by Country, Diagnostic and Interventional Guidewire Market, Europe, 2019 – 2029 (US$)837
Figure 21‑7: Market Value by Country, Diagnostic and Interventional Guidewire Market, Europe, 2019 – 2029 (€M)838
Figure 21‑8: Market Value by Country, Diagnostic and Interventional Guidewire Market, Europe, 2019 – 2029 (US$M)839
Figure 21‑9: Standard Guidewire Market, Europe, 2019 – 2029840
Figure 21‑10: Units Sold by Country, Standard Guidewire Market, Europe, 2019 – 2029841
Figure 21‑11: Average Selling Price by Country, Standard Guidewire Market, Europe, 2019 – 2029 (€)842
Figure 21‑12: Average Selling Price by Country, Standard Guidewire Market, Europe, 2019 – 2029 (US$)843
Figure 21‑13: Market Value by Country, Standard Guidewire Market, Europe, 2019 – 2029 (€M)844
Figure 21‑14: Market Value by Country, Standard Guidewire Market, Europe, 2019 – 2029 (US$M)845
Figure 21‑15: Hydrophilic Guidewire Market, Europe, 2019 – 2029846
Figure 21‑16: Units Sold by Country, Hydrophilic Guidewire Market, Europe, 2019 – 2029847
Figure 21‑17: Average Selling Price by Country, Hydrophilic Guidewire Market, Europe, 2019 – 2029 (€)848
Figure 21‑18: Average Selling Price by Country, Hydrophilic Guidewire Market, Europe, 2019 – 2029 (US$)849
Figure 21‑19: Market Value by Country, Hydrophilic Guidewire Market, Europe, 2019 – 2029 (€M)850
Figure 21‑20: Market Value by Country, Hydrophilic Guidewire Market, Europe, 2019 – 2029 (US$M)851
Figure 21‑21: Leading Competitors, Diagnostic and Interventional Guidewire Market, Europe, 2022856
Figure 22‑1: Introducer Sheath Market by Segment, Europe, 2019 – 2029 (€M)859
Figure 22‑2: Introducer Sheath Market by Segment, Europe, 2019 – 2029 (US$M)860
Figure 22‑3: Total Introducer Sheath Market, Europe, 2019 – 2029862
Figure 22‑4: Units Sold by Country, Introducer Sheath Market, Europe, 2019 – 2029863
Figure 22‑5: Average Selling Price by Country, Introducer Sheath Market, Europe, 2019 – 2029 (€)864
Figure 22‑6: Average Selling Price by Country, Introducer Sheath Market, Europe, 2019 – 2029 (US$)865
Figure 22‑7: Market Value by Country, Introducer Sheath Market, Europe, 2019 – 2029 (€M)866
Figure 22‑8: Market Value by Country, Introducer Sheath Market, Europe, 2019 – 2029 (US$M)867
Figure 22‑9: Standard Introducer Sheath Market, Europe, 2019 – 2029868
Figure 22‑10: Units Sold by Country, Standard Introducer Sheath Market, Europe, 2019 – 2029869
Figure 22‑11: Average Selling Price by Country, Standard Introducer Sheath Market, Europe, 2019 – 2029 (€)870
Figure 22‑12: Average Selling Price by Country, Standard Introducer Sheath Market, Europe, 2019 – 2029 (US$)871
Figure 22‑13: Market Value by Country, Standard Introducer Sheath Market, Europe, 2019 – 2029 (€M)872
Figure 22‑14: Market Value by Country, Standard Introducer Sheath Market, Europe, 2019 – 2029 (US$M)873
Figure 22‑15: Guiding Introducer Sheath Market, Europe, 2019 – 2029874
Figure 22‑16: Units Sold by Country, Guiding Introducer Sheath Market, Europe, 2019 – 2029875
Figure 22‑17: Average Selling Price by Country, Guiding Introducer Sheath Market, Europe, 2019 – 2029 (€)876
Figure 22‑18: Average Selling Price by Country, Guiding Introducer Sheath Market, Europe, 2019 – 2029 (US$)877
Figure 22‑19: Market Value by Country, Guiding Introducer Sheath Market, Europe, 2019 – 2029 (€M)878
Figure 22‑20: Market Value by Country, Guiding Introducer Sheath Market, Europe, 2019 – 2029 (US$M)879
Figure 22‑21: Leading Competitors, Introducer Sheath Market, Europe, 2022883
Figure 23‑1: Vascular Closure Device Market by Device Type, Europe, 2019 – 2029 (€M)887
Figure 23‑2: Vascular Closure Device Market by Device Type, Europe, 2019 – 2029 (US$M)888
Figure 23‑3: Vascular Closure Device Market by Approach, Europe, 2019 – 2029 (€M)889
Figure 23‑4: Vascular Closure Device Market by Approach, Europe, 2019 – 2029 (US$M)890
Figure 23‑5: Total Vascular Closure Device Market, Europe, 2019 – 2029892
Figure 23‑6: Units Sold by Country, Vascular Closure Device Market, Europe, 2019 – 2029893
Figure 23‑7: Average Selling Price by Country, Vascular Closure Device Market, Europe, 2019 – 2029 (€)894
Figure 23‑8: Average Selling Price by Country, Vascular Closure Device Market, Europe, 2019 – 2029 (US$)895
Figure 23‑9: Market Value by Country, Vascular Closure Device Market, Europe, 2019 – 2029 (€M)896
Figure 23‑10: Market Value by Country, Vascular Closure Device Market, Europe, 2019 – 2029 (US$M)897
Figure 23‑11: Invasive Vascular Closure Device Market by Segment, Europe, 2019 – 2029 (€M)898
Figure 23‑12: Invasive Vascular Closure Device Market by Segment, Europe, 2019 – 2029 (US$M)899
Figure 23‑13: Total Invasive Vascular Closure Device Market, Europe, 2019 – 2029899
Figure 23‑14: Units Sold by Country, Total Invasive Vascular Closure Device Market, Europe, 2019 – 2029900
Figure 23‑15: Average Selling Price by Country, Total Invasive Vascular Closure Device Market, Europe, 2019 – 2029 (€)901
Figure 23‑16: Average Selling Price by Country, Total Invasive Vascular Closure Device Market, Europe, 2019 – 2029 (US$)902
Figure 23‑17: Market Value by Country, Total Invasive Vascular Closure Device Market, Europe, 2019 – 2029 (€M)903
Figure 23‑18: Market Value by Country, Total Invasive Vascular Closure Device Market, Europe, 2019 – 2029 (US$M)904
Figure 23‑19: Small-Bore Vascular Closure Device Market, Europe, 2019 – 2029905
Figure 23‑20: Units Sold by Country, Small-Bore Vascular Closure Device Market, Europe, 2019 – 2029906
Figure 23‑21: Average Selling Price by Country, Small-Bore Vascular Closure Device Market, Europe, 2019 – 2029 (€)907
Figure 23‑22: Average Selling Price by Country, Small-Bore Vascular Closure Device Market, Europe, 2019 – 2029 (US$)908
Figure 23‑23: Market Value by Country, Small-Bore Vascular Closure Device Market, Europe, 2019 – 2029 (€M)909
Figure 23‑24: Market Value by Country, Small-Bore Vascular Closure Device Market, Europe, 2019 – 2029 (US$M)910
Figure 23‑25: Large-Bore Vascular Closure Device Market, Europe, 2019 – 2029912
Figure 23‑26: Units Sold by Country, Large-Bore Vascular Closure Device Market, Europe, 2019 – 2029913
Figure 23‑27: Average Selling Price by Country, Large-Bore Vascular Closure Device Market, Europe, 2019 – 2029 (€)914
Figure 23‑28: Average Selling Price by Country, Large-Bore Vascular Closure Device Market, Europe, 2019 – 2029 (US$)915
Figure 23‑29: Market Value by Country, Large-Bore Vascular Closure Device Market, Europe, 2019 – 2029 (€M)916
Figure 23‑30: Market Value by Country, Large-Bore Vascular Closure Device Market, Europe, 2019 – 2029 (US$M)917
Figure 23‑31: Non-Invasive Vascular Closure Device Market, Europe, 2019 – 2029918
Figure 23‑32: Units Sold by Country, Non-Invasive Vascular Closure Device Market, Europe, 2019 – 2029919
Figure 23‑33: Average Selling Price by Country, Non-Invasive Vascular Closure Device Market, Europe, 2019 – 2029 (€)920
Figure 23‑34: Average Selling Price by Country, Non-Invasive Vascular Closure Device Market, Europe, 2019 – 2029 (US$)921
Figure 23‑35: Market Value by Country, Non-Invasive Vascular Closure Device Market, Europe, 2019 – 2029 (€M)922
Figure 23‑36: Market Value by Country, Non-Invasive Vascular Closure Device Market, Europe, 2019 – 2029 (US$M)923
Figure 23‑37: Radial Vascular Closure Device Market, Europe, 2019 – 2029924
Figure 23‑38: Units Sold by Country, Radial Vascular Closure Device Market, Europe, 2019 – 2029925
Figure 23‑39: Average Selling Price by Country, Radial Vascular Closure Device Market, Europe, 2019 – 2029 (€)926
Figure 23‑40: Average Selling Price by Country, Radial Vascular Closure Device Market, Europe, 2019 – 2029 (US$)927
Figure 23‑41: Market Value by Country, Radial Vascular Closure Device Market, Europe, 2019 – 2029 (€M)928
Figure 23‑42: Market Value by Country, Radial Vascular Closure Device Market, Europe, 2019 – 2029 (US$M)929
Figure 23‑43: Femoral Vascular Closure Device Market, Europe, 2019 – 2029930
Figure 23‑44: Units Sold by Country, Femoral Vascular Closure Device Market, Europe, 2019 – 2029931
Figure 23‑45: Average Selling Price by Country, Femoral Vascular Closure Device Market, Europe, 2019 – 2029 (€)932
Figure 23‑46: Average Selling Price by Country, Femoral Vascular Closure Device Market, Europe, 2019 – 2029 (US$)933
Figure 23‑47: Market Value by Country, Femoral Vascular Closure Device Market, Europe, 2019 – 2029 (€M)934
Figure 23‑48: Market Value by Country, Femoral Vascular Closure Device Market, Europe, 2019 – 2029 (US$M)935
Figure 23‑49: Leading Competitors, Vascular Closure Device Market by Device Type, Europe, 2022941
Figure 23‑50: Leading Competitors, Vascular Closure Device Market by Approach, Europe, 2022941
Figure 24‑1: Transcatheter Embolization Market by Segment, Europe, 2019 – 2029 (€M)946
Figure 24‑2: Transcatheter Embolization Market by Segment, Europe, 2019 – 2029 (US$M)947
Figure 24‑3: Particle Embolization Market by Segment, Europe, 2019 – 2029 (€M)951
Figure 24‑4: Particle Embolization Market by Segment, Europe, 2019 – 2029 (US$M)951
Figure 24‑5: Particle Embolization Market, Europe, 2019 – 2029952
Figure 24‑6: Units Sold by Country, Particle Embolization Market, Europe, 2019 – 2029953
Figure 24‑7: Average Selling Price by Country, Particle Embolization Market, Europe, 2019 – 2029 (€)954
Figure 24‑8: Average Selling Price by Country, Particle Embolization Market, Europe, 2019 – 2029 (US$)955
Figure 24‑9: Market Value by Country, Particle Embolization Market, Europe, 2019 – 2029 (€M)956
Figure 24‑10: Market Value by Country, Particle Embolization Market, Europe, 2019 – 2029 (US$M)957
Figure 24‑11: PVA Particle Market, Europe, 2019 – 2029958
Figure 24‑12: Units Sold by Country, PVA Particle Market, Europe, 2019 – 2029959
Figure 24‑13: Average Selling Price by Country, PVA Particle Market, Europe, 2019 – 2029 (€)960
Figure 24‑14: Average Selling Price by Country, PVA Particle Market, Europe, 2019 – 2029 (US$)961
Figure 24‑15: Market Value by Country, PVA Particle Market, Europe, 2019 – 2029 (€M)962
Figure 24‑16: Market Value by Country, PVA Particle Market, Europe, 2019 – 2029 (US$M)963
Figure 24‑17: Microsphere Market, Europe, 2019 – 2029964
Figure 24‑18: Units Sold by Country, Microsphere Market, Europe, 2019 – 2029965
Figure 24‑19: Average Selling Price by Country, Microsphere Market, Europe, 2019 – 2029 (€)966
Figure 24‑20: Average Selling Price by Country, Microsphere Market, Europe, 2019 – 2029 (US$)967
Figure 24‑21: Market Value by Country, Microsphere Market, Europe, 2019 – 2029 (€M)968
Figure 24‑22: Market Value by Country, Microsphere Market, Europe, 2019 – 2029 (US$M)969
Figure 24‑23: Drug-Eluting Particle Market, Europe, 2019 – 2029970
Figure 24‑24: Units Sold by Country, Drug-Eluting Particle Market, Europe, 2019 – 2029971
Figure 24‑25: Average Selling Price by Country, Drug-Eluting Particle Market, Europe, 2019 – 2029 (€)972
Figure 24‑26: Average Selling Price by Country, Drug-Eluting Particle Market, Europe, 2019 – 2029 (US$)973
Figure 24‑27: Market Value by Country, Drug-Eluting Particle Market, Europe, 2019 – 2029 (€M)974
Figure 24‑28: Market Value by Country, Drug-Eluting Particle Market, Europe, 2019 – 2029 (US$M)975
Figure 24‑29: Radioactive Particle Market, Europe, 2019 – 2029976
Figure 24‑30: Units Sold by Country, Radioactive Particle Market, Europe, 2019 – 2029977
Figure 24‑31: Average Selling Price by Country, Radioactive Particle Market, Europe, 2019 – 2029 (€)978
Figure 24‑32: Average Selling Price by Country, Radioactive Particle Market, Europe, 2019 – 2029 (US$)979
Figure 24‑33: Market Value by Country, Radioactive Particle Market, Europe, 2019 – 2029 (€M)980
Figure 24‑34: Market Value by Country, Radioactive Particle Market, Europe, 2019 – 2029 (US$M)981
Figure 24‑35: Coil Embolization Market by Segment, Europe, 2019 – 2029 (€M)983
Figure 24‑36: Coil Embolization Market by Segment, Europe, 2019 – 2029 (US$M)983
Figure 24‑37: Total Coil Embolization Market, Europe, 2019 – 2029984
Figure 24‑38: Units Sold by Country, Total Coil Embolization Market, Europe, 2019 – 2029985
Figure 24‑39: Average Selling Price by Country, Total Coil Embolization Market, Europe, 2019 – 2029 (€)986
Figure 24‑40: Average Selling Price by Country, Total Coil Embolization Market, Europe, 2019 – 2029 (US$)987
Figure 24‑41: Market Value by Country, Total Coil Embolization Market, Europe, 2019 – 2029 (€M)988
Figure 24‑42: Market Value by Country, Total Coil Embolization Market, Europe, 2019 – 2029 (US$M)989
Figure 24‑43: Pushable Coil Market, Europe, 2019 – 2029990
Figure 24‑44: Units Sold by Country, Pushable Coil Market, Europe, 2019 – 2029991
Figure 24‑45: Average Selling Price by Country, Pushable Coil Market, Europe, 2019 – 2029 (€)992
Figure 24‑46: Average Selling Price by Country, Pushable Coil Market, Europe, 2019 – 2029 (US$)993
Figure 24‑47: Market Value by Country, Pushable Coil Market, Europe, 2019 – 2029 (€M)994
Figure 24‑48: Market Value by Country, Pushable Coil Market, Europe, 2019 – 2029 (US$M)995
Figure 24‑49: Detachable Coil Market, Europe, 2019 – 2029996
Figure 24‑50: Units Sold by Country, Detachable Coil Market, Europe, 2019 – 2029997
Figure 24‑51: Average Selling Price by Country, Detachable Coil Market, Europe, 2019 – 2029 (€)998
Figure 24‑52: Average Selling Price by Country, Detachable Coil Market, Europe, 2019 – 2029 (US$)999
Figure 24‑53: Market Value by Country, Detachable Coil Market, Europe, 2019 – 2029 (€M)1000
Figure 24‑54: Market Value by Country, Detachable Coil Market, Europe, 2019 – 2029 (US$M)1001
Figure 24‑55: Liquid Embolization Market, Europe, 2019 – 20291002
Figure 24‑56: Units Sold by Country, Liquid Embolization Market, Europe, 2019 – 20291003
Figure 24‑57: Average Selling Price by Country, Liquid Embolization Market, Europe, 2019 – 2029 (€)1004
Figure 24‑58: Average Selling Price by Country, Liquid Embolization Market, Europe, 2019 – 2029 (US$)1005
Figure 24‑59: Market Value by Country, Liquid Embolization Market, Europe, 2019 – 2029 (€M)1006
Figure 24‑60: Market Value by Country, Liquid Embolization Market, Europe, 2019 – 2029 (US$M)1007
Figure 24‑61: Plug Embolization Market, Europe, 2019 – 20291009
Figure 24‑62: Units Sold by Country, Plug Embolization Market, Europe, 2019 – 20291010
Figure 24‑63: Average Selling Price by Country, Plug Embolization Market, Europe, 2019 – 2029 (€)1011
Figure 24‑64: Average Selling Price by Country, Plug Embolization Market, Europe, 2019 – 2029 (US$)1012
Figure 24‑65: Market Value by Country, Plug Embolization Market, Europe, 2019 – 2029 (€M)1013
Figure 24‑66: Market Value by Country, Plug Embolization Market, Europe, 2019 – 2029 (US$M)1014
Figure 24‑67: Leading Competitors, Transcatheter Embolization Market, Europe, 20221021
Figure 25‑1: Peripheral IVUS Market, Europe, 2019 – 20291026
Figure 25‑2: Units Sold by Country, Peripheral IVUS Market, Europe, 2019 – 20291028
Figure 25‑3: Average Selling Price by Country, Peripheral IVUS Market, Europe, 2019 – 2029 (€)1029
Figure 25‑4: Average Selling Price by Country, Peripheral IVUS Market, Europe, 2019 – 2029 (US$)1030
Figure 25‑5: Market Value by Country, Peripheral IVUS Market, Europe, 2019 – 2029 (€M)1031
Figure 25‑6: Market Value by Country, Peripheral IVUS Market, Europe, 2019 – 2029 (US$M)1032
Figure 25‑7: Leading Competitors, Peripheral IVUS Market, Europe, 20221036
 

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

  • 2023
  • 2019-2029
  • Europe
  • 06/05/23
  • 1041
  • MedSuite
SKU: iDATA_EUPV23_MS Categories: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
0
    0
    Your Cart
    Your cart is emptyReturn to Report Library